JP2010514751A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010514751A5 JP2010514751A5 JP2009543566A JP2009543566A JP2010514751A5 JP 2010514751 A5 JP2010514751 A5 JP 2010514751A5 JP 2009543566 A JP2009543566 A JP 2009543566A JP 2009543566 A JP2009543566 A JP 2009543566A JP 2010514751 A5 JP2010514751 A5 JP 2010514751A5
- Authority
- JP
- Japan
- Prior art keywords
- aza
- bicyclo
- thiazole
- hex
- ylmethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 2,3-dihydro-benzofuranyl- Chemical group 0.000 claims 53
- 125000001424 substituent group Chemical group 0.000 claims 22
- 150000001875 compounds Chemical class 0.000 claims 20
- 125000000217 alkyl group Chemical group 0.000 claims 16
- 125000000623 heterocyclic group Chemical group 0.000 claims 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 12
- 125000003118 aryl group Chemical group 0.000 claims 10
- 229910052736 halogen Inorganic materials 0.000 claims 10
- 150000002367 halogens Chemical class 0.000 claims 10
- 208000035475 disorder Diseases 0.000 claims 9
- 208000002193 Pain Diseases 0.000 claims 8
- 150000003839 salts Chemical class 0.000 claims 8
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 7
- QRDZFPUVLYEQTA-UHFFFAOYSA-N quinoline-8-carboxylic acid Chemical compound C1=CN=C2C(C(=O)O)=CC=CC2=C1 QRDZFPUVLYEQTA-UHFFFAOYSA-N 0.000 claims 7
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 7
- 230000036407 pain Effects 0.000 claims 6
- 208000011580 syndromic disease Diseases 0.000 claims 6
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 claims 5
- 125000003545 alkoxy group Chemical group 0.000 claims 5
- CHDSHBWEGSCEDX-UHFFFAOYSA-N 2,3-dihydro-1-benzofuran-4-carboxylic acid Chemical compound OC(=O)C1=CC=CC2=C1CCO2 CHDSHBWEGSCEDX-UHFFFAOYSA-N 0.000 claims 4
- 230000004064 dysfunction Effects 0.000 claims 4
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 4
- 208000020016 psychiatric disease Diseases 0.000 claims 4
- 208000019901 Anxiety disease Diseases 0.000 claims 3
- 206010010904 Convulsion Diseases 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 208000004296 neuralgia Diseases 0.000 claims 3
- 201000000980 schizophrenia Diseases 0.000 claims 3
- 230000001568 sexual effect Effects 0.000 claims 3
- VPYXATIIMHQAPR-UHFFFAOYSA-N 1,2-benzoxazole-3-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=NOC2=C1 VPYXATIIMHQAPR-UHFFFAOYSA-N 0.000 claims 2
- VCLSWKVAHAJSFL-UHFFFAOYSA-N 2,3-dihydro-1,4-benzodioxine-5-carboxylic acid Chemical compound O1CCOC2=C1C=CC=C2C(=O)O VCLSWKVAHAJSFL-UHFFFAOYSA-N 0.000 claims 2
- 125000000850 2H-chromenyl group Chemical group O1C(C=CC2=CC=CC=C12)* 0.000 claims 2
- IJEUISLJVBUNRE-UHFFFAOYSA-N 3,5-dimethyl-1,2-oxazole-4-carboxylic acid Chemical compound CC1=NOC(C)=C1C(O)=O IJEUISLJVBUNRE-UHFFFAOYSA-N 0.000 claims 2
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims 2
- AVBKMSSLAIKOGM-UHFFFAOYSA-N 4-methoxyquinoline-2-carboxylic acid Chemical compound C1=CC=C2C(OC)=CC(C(O)=O)=NC2=C1 AVBKMSSLAIKOGM-UHFFFAOYSA-N 0.000 claims 2
- VSQMBZXCDDTZAF-UHFFFAOYSA-N 6-methylimidazo[2,1-b][1,3]thiazole-5-carboxylic acid Chemical compound S1C=CN2C(C(O)=O)=C(C)N=C21 VSQMBZXCDDTZAF-UHFFFAOYSA-N 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 208000000044 Amnesia Diseases 0.000 claims 2
- 208000031091 Amnestic disease Diseases 0.000 claims 2
- 206010002091 Anaesthesia Diseases 0.000 claims 2
- 208000024172 Cardiovascular disease Diseases 0.000 claims 2
- 208000019888 Circadian rhythm sleep disease Diseases 0.000 claims 2
- 208000012661 Dyskinesia Diseases 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 208000004454 Hyperalgesia Diseases 0.000 claims 2
- 208000012902 Nervous system disease Diseases 0.000 claims 2
- 208000025966 Neurological disease Diseases 0.000 claims 2
- 208000028017 Psychotic disease Diseases 0.000 claims 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 claims 2
- 206010046543 Urinary incontinence Diseases 0.000 claims 2
- 206010047700 Vomiting Diseases 0.000 claims 2
- 230000032683 aging Effects 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- 230000006986 amnesia Effects 0.000 claims 2
- 230000037005 anaesthesia Effects 0.000 claims 2
- 125000003016 chromanyl group Chemical group O1C(CCC2=CC=CC=C12)* 0.000 claims 2
- 208000010877 cognitive disease Diseases 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 230000035622 drinking Effects 0.000 claims 2
- 235000021271 drinking Nutrition 0.000 claims 2
- 235000005686 eating Nutrition 0.000 claims 2
- 206010015037 epilepsy Diseases 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 230000002267 hypothalamic effect Effects 0.000 claims 2
- KMAKOBLIOCQGJP-UHFFFAOYSA-N indole-3-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=CNC2=C1 KMAKOBLIOCQGJP-UHFFFAOYSA-N 0.000 claims 2
- 206010022437 insomnia Diseases 0.000 claims 2
- 230000000302 ischemic effect Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000003340 mental effect Effects 0.000 claims 2
- 208000021722 neuropathic pain Diseases 0.000 claims 2
- 201000001119 neuropathy Diseases 0.000 claims 2
- 230000007823 neuropathy Effects 0.000 claims 2
- 208000033808 peripheral neuropathy Diseases 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 229940001470 psychoactive drug Drugs 0.000 claims 2
- 239000004089 psychotropic agent Substances 0.000 claims 2
- 230000001850 reproductive effect Effects 0.000 claims 2
- 230000008673 vomiting Effects 0.000 claims 2
- XYRXQPDMBJNYIU-UHFFFAOYSA-N 1,2-dimethylindole-3-carboxylic acid Chemical compound C1=CC=C2N(C)C(C)=C(C(O)=O)C2=C1 XYRXQPDMBJNYIU-UHFFFAOYSA-N 0.000 claims 1
- XBFRQODQXBMILB-UHFFFAOYSA-N 1,3-benzothiazole-4-carboxylic acid Chemical compound OC(=O)C1=CC=CC2=C1N=CS2 XBFRQODQXBMILB-UHFFFAOYSA-N 0.000 claims 1
- ORSZGLLQNYSMNO-UHFFFAOYSA-N 1,3-benzothiazole-7-carboxylic acid Chemical compound OC(=O)C1=CC=CC2=C1SC=N2 ORSZGLLQNYSMNO-UHFFFAOYSA-N 0.000 claims 1
- KRCCCWVXRVDONW-UHFFFAOYSA-N 1,3-benzoxazole-4-carboxylic acid Chemical compound OC(=O)C1=CC=CC2=C1N=CO2 KRCCCWVXRVDONW-UHFFFAOYSA-N 0.000 claims 1
- JHTQTAYWCUAENJ-UHFFFAOYSA-N 1,3-benzoxazole-7-carboxylic acid Chemical compound OC(=O)C1=CC=CC2=C1OC=N2 JHTQTAYWCUAENJ-UHFFFAOYSA-N 0.000 claims 1
- LJPSRTWIAXVPIS-UHFFFAOYSA-N 1-benzothiophene-7-carboxylic acid Chemical compound OC(=O)C1=CC=CC2=C1SC=C2 LJPSRTWIAXVPIS-UHFFFAOYSA-N 0.000 claims 1
- DTJLXXLXQPOQBZ-UHFFFAOYSA-N 1-ethyl-3-methylpyrazole-4-carboxylic acid Chemical compound CCN1C=C(C(O)=O)C(C)=N1 DTJLXXLXQPOQBZ-UHFFFAOYSA-N 0.000 claims 1
- YDGHXEVBZZGFLL-KPFFTGBYSA-N 1-ethyl-n-[[(1s,3s,5s)-2-[5-(3-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-3-methylpyrazole-4-carboxamide Chemical compound CC1=NN(CC)C=C1C(=O)NC[C@H]1N(C(=O)C2=C(SC(C)=N2)C=2C=C(F)C=CC=2)[C@H]2C[C@H]2C1 YDGHXEVBZZGFLL-KPFFTGBYSA-N 0.000 claims 1
- BHXVYTQDWMQVBI-UHFFFAOYSA-N 1h-indazole-3-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=NNC2=C1 BHXVYTQDWMQVBI-UHFFFAOYSA-N 0.000 claims 1
- ZVXXYWHMRDJFDL-HFTRVMKXSA-N 2,2-difluoro-n-[[(1s,3s,5s)-2-[5-(3-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1,3-benzodioxole-4-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3OC(F)(F)OC=3C=CC=2)=C1C1=CC=CC(F)=C1 ZVXXYWHMRDJFDL-HFTRVMKXSA-N 0.000 claims 1
- YXXWGZCPGQJCRW-GIWBLDEGSA-N 2,2-dimethyl-n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-3h-1-benzofuran-7-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3OC(C)(C)CC=3C=CC=2)=C1C1=CC=CC(C)=C1 YXXWGZCPGQJCRW-GIWBLDEGSA-N 0.000 claims 1
- QRWZFUBHOQWUGH-UHFFFAOYSA-N 2,5-dimethylpyrazole-3-carboxylic acid Chemical compound CC=1C=C(C(O)=O)N(C)N=1 QRWZFUBHOQWUGH-UHFFFAOYSA-N 0.000 claims 1
- CZKIDVYMBRVQBU-UHFFFAOYSA-N 2-chloro-1,3-benzothiazole-4-carboxylic acid Chemical compound OC(=O)C1=CC=CC2=C1N=C(Cl)S2 CZKIDVYMBRVQBU-UHFFFAOYSA-N 0.000 claims 1
- RZYJINMBGDAXJP-LQWHRVPQSA-N 2-chloro-n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]benzamide Chemical compound C([C@@H]1C[C@@H]2C[C@@H]2N1C(=O)C=1N=C(SC=1C=1C=C(C)C=CC=1)C)NC(=O)C1=CC=CC=C1Cl RZYJINMBGDAXJP-LQWHRVPQSA-N 0.000 claims 1
- KVQVGIGILHSZSU-AABGKKOBSA-N 2-ethyl-5-methyl-n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]pyrazole-3-carboxamide Chemical compound CCN1N=C(C)C=C1C(=O)NC[C@H]1N(C(=O)C2=C(SC(C)=N2)C=2C=C(C)C=CC=2)[C@H]2C[C@H]2C1 KVQVGIGILHSZSU-AABGKKOBSA-N 0.000 claims 1
- ISNGGIADAFLJMJ-NEWSRXKRSA-N 2-ethyl-n-[[(1s,3s,5s)-2-[5-(3-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-5-methylpyrazole-3-carboxamide Chemical compound CCN1N=C(C)C=C1C(=O)NC[C@H]1N(C(=O)C2=C(SC(C)=N2)C=2C=C(F)C=CC=2)[C@H]2C[C@H]2C1 ISNGGIADAFLJMJ-NEWSRXKRSA-N 0.000 claims 1
- KDPOFQJHFWJFCB-UHFFFAOYSA-N 2-methyl-1,3-benzoxazole-7-carboxylic acid Chemical compound C1=CC(C(O)=O)=C2OC(C)=NC2=C1 KDPOFQJHFWJFCB-UHFFFAOYSA-N 0.000 claims 1
- QMVZMKJWEQFJDP-UHFFFAOYSA-N 2h-chromene-5-carboxylic acid Chemical compound O1CC=CC2=C1C=CC=C2C(=O)O QMVZMKJWEQFJDP-UHFFFAOYSA-N 0.000 claims 1
- FTOZLHKBGJHVNK-GIVPXCGWSA-N 3-bromo-n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]benzamide Chemical compound C([C@@H]1C[C@@H]2C[C@@H]2N1C(=O)C=1N=C(SC=1C=1C=C(C)C=CC=1)C)NC(=O)C1=CC=CC(Br)=C1 FTOZLHKBGJHVNK-GIVPXCGWSA-N 0.000 claims 1
- AZAHJSDNHZYCDQ-DXIQSLLYSA-N 3-chloro-2-methyl-n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]benzamide Chemical compound C([C@@H]1C[C@@H]2C[C@@H]2N1C(=O)C=1N=C(SC=1C=1C=C(C)C=CC=1)C)NC(=O)C1=CC=CC(Cl)=C1C AZAHJSDNHZYCDQ-DXIQSLLYSA-N 0.000 claims 1
- DTTGYKRNHMRWHY-GIVPXCGWSA-N 3-iodo-n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]benzamide Chemical compound C([C@@H]1C[C@@H]2C[C@@H]2N1C(=O)C=1N=C(SC=1C=1C=C(C)C=CC=1)C)NC(=O)C1=CC=CC(I)=C1 DTTGYKRNHMRWHY-GIVPXCGWSA-N 0.000 claims 1
- AGOAENRCPQZMFP-URVUXULASA-N 3-methoxy-n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]benzamide Chemical compound COC1=CC=CC(C(=O)NC[C@H]2N([C@H]3C[C@H]3C2)C(=O)C2=C(SC(C)=N2)C=2C=C(C)C=CC=2)=C1 AGOAENRCPQZMFP-URVUXULASA-N 0.000 claims 1
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 claims 1
- GCEPRJCFTSFVDA-QYZOEREBSA-N 3-methyl-n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]imidazo[2,1-b][1,3]thiazole-2-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C2=C(N3C=CN=C3S2)C)=C1C1=CC=CC(C)=C1 GCEPRJCFTSFVDA-QYZOEREBSA-N 0.000 claims 1
- OYOMMXTUBZYEGS-UHFFFAOYSA-N 3-methylimidazo[2,1-b][1,3]thiazole-5-carboxylic acid Chemical compound C1=C(C(O)=O)N2C(C)=CSC2=N1 OYOMMXTUBZYEGS-UHFFFAOYSA-N 0.000 claims 1
- JKEUXKJMBNQDRK-LMNJBCLMSA-N 4-chloro-2-methoxy-n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]benzamide Chemical compound COC1=CC(Cl)=CC=C1C(=O)NC[C@H]1N(C(=O)C2=C(SC(C)=N2)C=2C=C(C)C=CC=2)[C@H]2C[C@H]2C1 JKEUXKJMBNQDRK-LMNJBCLMSA-N 0.000 claims 1
- DFLOUBRTXQQGOE-DYXWJJEUSA-N 4-methoxy-n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-3-(trifluoromethyl)benzamide Chemical compound C1=C(C(F)(F)F)C(OC)=CC=C1C(=O)NC[C@H]1N(C(=O)C2=C(SC(C)=N2)C=2C=C(C)C=CC=2)[C@H]2C[C@H]2C1 DFLOUBRTXQQGOE-DYXWJJEUSA-N 0.000 claims 1
- ZGWGSEUMABQEMD-UHFFFAOYSA-N 4-methyl-1,3-thiazole-5-carboxylic acid Chemical compound CC=1N=CSC=1C(O)=O ZGWGSEUMABQEMD-UHFFFAOYSA-N 0.000 claims 1
- XNZRBTUVFURPDX-QTEQDKRBSA-N 4-methyl-n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1,4-benzoxazine-8-carboxamide Chemical compound N1([C@H]2C[C@H]2C[C@H]1CNC(=O)C1=CC=CC2=C1OCCN2C)C(=O)C=1N=C(C)SC=1C1=CC=CC(C)=C1 XNZRBTUVFURPDX-QTEQDKRBSA-N 0.000 claims 1
- QXXLUBQLXMROMY-NWSQWKLXSA-N 5-fluoro-1-methyl-n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]indole-2-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2N(C3=CC=C(F)C=C3C=2)C)=C1C1=CC=CC(C)=C1 QXXLUBQLXMROMY-NWSQWKLXSA-N 0.000 claims 1
- SQVZFICXVOEKNL-WVBUVRCRSA-N 5-fluoro-n-[[(1s,3s,5s)-2-[5-(3-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1h-indole-2-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2NC3=CC=C(F)C=C3C=2)=C1C1=CC=CC(F)=C1 SQVZFICXVOEKNL-WVBUVRCRSA-N 0.000 claims 1
- JFOACJIGTATYPC-IKGGRYGDSA-N 6-chloro-n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2N3C=CSC3=NC=2Cl)=C1C1=CC=CC(C)=C1 JFOACJIGTATYPC-IKGGRYGDSA-N 0.000 claims 1
- RLHABKYWDKVMLH-AGHHOFFYSA-N 6-fluoro-n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-4h-1,3-benzodioxine-8-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3OCOCC=3C=C(F)C=2)=C1C1=CC=CC(C)=C1 RLHABKYWDKVMLH-AGHHOFFYSA-N 0.000 claims 1
- BZHUUDQQILZKGO-JJXUHFIVSA-N 6-fluoro-n-[[(1s,3s,5s)-2-[5-(3-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-4h-1,3-benzodioxine-8-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3OCOCC=3C=C(F)C=2)=C1C1=CC=CC(F)=C1 BZHUUDQQILZKGO-JJXUHFIVSA-N 0.000 claims 1
- NAGXUKYONQYLQK-HBFSDRIKSA-N 6-methyl-n-[[(1s,3s,5s)-2-(2-methyl-4-phenylpyrimidine-5-carbonyl)-2-azabicyclo[3.1.0]hexan-3-yl]methyl]imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound N1([C@H]2C[C@H]2C[C@H]1CNC(=O)C=1N2C=CSC2=NC=1C)C(=O)C1=CN=C(C)N=C1C1=CC=CC=C1 NAGXUKYONQYLQK-HBFSDRIKSA-N 0.000 claims 1
- WRHNJFXQMMMBGX-GJYPPUQNSA-N 6-methyl-n-[[(1s,3s,5s)-2-(2-pyrazol-1-ylbenzoyl)-2-azabicyclo[3.1.0]hexan-3-yl]methyl]imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound N1([C@H]2C[C@H]2C[C@H]1CNC(=O)C=1N2C=CSC2=NC=1C)C(=O)C1=CC=CC=C1N1C=CC=N1 WRHNJFXQMMMBGX-GJYPPUQNSA-N 0.000 claims 1
- BBILWLLJFSWYFO-QYZOEREBSA-N 6-methyl-n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2N3C=CSC3=NC=2C)=C1C1=CC=CC(C)=C1 BBILWLLJFSWYFO-QYZOEREBSA-N 0.000 claims 1
- SNISEKWZQSWMSM-AABGKKOBSA-N 6-methyl-n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]pyrrolo[2,1-b][1,3]thiazole-7-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C2=C3SC=CN3C=C2C)=C1C1=CC=CC(C)=C1 SNISEKWZQSWMSM-AABGKKOBSA-N 0.000 claims 1
- GVOZOHSZUJYIQL-UHFFFAOYSA-N 7-chloro-1-benzofuran-4-carboxylic acid Chemical compound OC(=O)C1=CC=C(Cl)C2=C1C=CO2 GVOZOHSZUJYIQL-UHFFFAOYSA-N 0.000 claims 1
- VFCOHQGGTMMONH-ZZGJPJSFSA-N 7-chloro-2-methoxy-n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound N1([C@H]2C[C@H]2C[C@H]1CNC(=O)C1=CC=C(Cl)C2=C1CC(O2)OC)C(=O)C=1N=C(C)SC=1C1=CC=CC(C)=C1 VFCOHQGGTMMONH-ZZGJPJSFSA-N 0.000 claims 1
- KELIAGSOLXPTAY-UHFFFAOYSA-N 7-fluoro-1-benzofuran-4-carboxylic acid Chemical compound OC(=O)C1=CC=C(F)C2=C1C=CO2 KELIAGSOLXPTAY-UHFFFAOYSA-N 0.000 claims 1
- OPXMVZLSLQAXPQ-MMOPVJDHSA-N 7-fluoro-n-[[(1s,3s,5s)-2-[5-(3-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1h-indole-2-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2NC3=C(F)C=CC=C3C=2)=C1C1=CC=CC(F)=C1 OPXMVZLSLQAXPQ-MMOPVJDHSA-N 0.000 claims 1
- 206010000599 Acromegaly Diseases 0.000 claims 1
- 208000003200 Adenoma Diseases 0.000 claims 1
- 206010001233 Adenoma benign Diseases 0.000 claims 1
- 208000007848 Alcoholism Diseases 0.000 claims 1
- 201000000736 Amenorrhea Diseases 0.000 claims 1
- 206010001928 Amenorrhoea Diseases 0.000 claims 1
- 206010002383 Angina Pectoris Diseases 0.000 claims 1
- 208000008035 Back Pain Diseases 0.000 claims 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 claims 1
- 208000020925 Bipolar disease Diseases 0.000 claims 1
- 208000002381 Brain Hypoxia Diseases 0.000 claims 1
- 208000003174 Brain Neoplasms Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 206010007556 Cardiac failure acute Diseases 0.000 claims 1
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 claims 1
- 208000017164 Chronobiology disease Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 208000019736 Cranial nerve disease Diseases 0.000 claims 1
- 208000020406 Creutzfeldt Jacob disease Diseases 0.000 claims 1
- 208000003407 Creutzfeldt-Jakob Syndrome Diseases 0.000 claims 1
- 208000010859 Creutzfeldt-Jakob disease Diseases 0.000 claims 1
- 208000014311 Cushing syndrome Diseases 0.000 claims 1
- 206010011878 Deafness Diseases 0.000 claims 1
- 206010012218 Delirium Diseases 0.000 claims 1
- 206010012289 Dementia Diseases 0.000 claims 1
- 208000016192 Demyelinating disease Diseases 0.000 claims 1
- 201000004624 Dermatitis Diseases 0.000 claims 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 claims 1
- 208000025967 Dissociative Identity disease Diseases 0.000 claims 1
- 206010013883 Dwarfism Diseases 0.000 claims 1
- 208000032928 Dyslipidaemia Diseases 0.000 claims 1
- 208000030814 Eating disease Diseases 0.000 claims 1
- 206010014733 Endometrial cancer Diseases 0.000 claims 1
- 206010014759 Endometrial neoplasm Diseases 0.000 claims 1
- 208000020564 Eye injury Diseases 0.000 claims 1
- 208000002091 Febrile Seizures Diseases 0.000 claims 1
- 208000019454 Feeding and Eating disease Diseases 0.000 claims 1
- 208000011688 Generalised anxiety disease Diseases 0.000 claims 1
- 201000005569 Gout Diseases 0.000 claims 1
- 206010019233 Headaches Diseases 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 claims 1
- 208000032843 Hemorrhage Diseases 0.000 claims 1
- 208000016988 Hemorrhagic Stroke Diseases 0.000 claims 1
- 208000035154 Hyperesthesia Diseases 0.000 claims 1
- 208000031226 Hyperlipidaemia Diseases 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 206010020843 Hyperthermia Diseases 0.000 claims 1
- 206010058359 Hypogonadism Diseases 0.000 claims 1
- 208000001953 Hypotension Diseases 0.000 claims 1
- 208000028482 Hypothalamic disease Diseases 0.000 claims 1
- 206010070511 Hypoxic-ischaemic encephalopathy Diseases 0.000 claims 1
- 206010022489 Insulin Resistance Diseases 0.000 claims 1
- 201000006347 Intellectual Disability Diseases 0.000 claims 1
- 208000032382 Ischaemic stroke Diseases 0.000 claims 1
- 208000001456 Jet Lag Syndrome Diseases 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- 208000007177 Left Ventricular Hypertrophy Diseases 0.000 claims 1
- 201000006792 Lennox-Gastaut syndrome Diseases 0.000 claims 1
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 1
- 208000019695 Migraine disease Diseases 0.000 claims 1
- 206010061296 Motor dysfunction Diseases 0.000 claims 1
- 208000016285 Movement disease Diseases 0.000 claims 1
- 208000008238 Muscle Spasticity Diseases 0.000 claims 1
- 208000029578 Muscle disease Diseases 0.000 claims 1
- 206010028813 Nausea Diseases 0.000 claims 1
- NNXMEKCQTGLZKA-JQSLRTAOSA-N O1CCC=2C1=CC=CC2C(=O)O.CC=2C=C(C=C(C2)C)C2=C(N=C(S2)C)C(=O)N2[C@H]1C[C@H]1C[C@H]2CNC(=O)C=2C=CC=C1C2CCO1 Chemical compound O1CCC=2C1=CC=CC2C(=O)O.CC=2C=C(C=C(C2)C)C2=C(N=C(S2)C)C(=O)N2[C@H]1C[C@H]1C[C@H]2CNC(=O)C=2C=CC=C1C2CCO1 NNXMEKCQTGLZKA-JQSLRTAOSA-N 0.000 claims 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 claims 1
- 102000002512 Orexin Human genes 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 claims 1
- 206010033664 Panic attack Diseases 0.000 claims 1
- 208000006199 Parasomnias Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 206010034759 Petit mal epilepsy Diseases 0.000 claims 1
- 206010034918 Phobic avoidance Diseases 0.000 claims 1
- 208000014993 Pituitary disease Diseases 0.000 claims 1
- 208000004550 Postoperative Pain Diseases 0.000 claims 1
- 206010036832 Prolactinoma Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 208000006262 Psychological Sexual Dysfunctions Diseases 0.000 claims 1
- 206010037660 Pyrexia Diseases 0.000 claims 1
- 206010038389 Renal cancer Diseases 0.000 claims 1
- 208000005793 Restless legs syndrome Diseases 0.000 claims 1
- 208000017442 Retinal disease Diseases 0.000 claims 1
- 206010038923 Retinopathy Diseases 0.000 claims 1
- 208000027520 Somatoform disease Diseases 0.000 claims 1
- 208000029033 Spinal Cord disease Diseases 0.000 claims 1
- 208000007107 Stomach Ulcer Diseases 0.000 claims 1
- 208000032851 Subarachnoid Hemorrhage Diseases 0.000 claims 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 claims 1
- 208000025371 Taste disease Diseases 0.000 claims 1
- 208000011622 Testicular disease Diseases 0.000 claims 1
- 208000009205 Tinnitus Diseases 0.000 claims 1
- 206010044565 Tremor Diseases 0.000 claims 1
- 206010046555 Urinary retention Diseases 0.000 claims 1
- 201000004810 Vascular dementia Diseases 0.000 claims 1
- PLQHTLOAZNLRAD-NRUUGDAUSA-N [(1S,3S,5S)-3-(aminomethyl)-2-azabicyclo[3.1.0]hexan-2-yl]-[5-(2,3-dichlorophenyl)-2-methyl-1,3-thiazol-4-yl]methanone Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CN)=C1C1=CC=CC(Cl)=C1Cl PLQHTLOAZNLRAD-NRUUGDAUSA-N 0.000 claims 1
- OCPFLHDEAUPJKB-SQNIBIBYSA-N [(1s,3s,5s)-3-[[(4,6-dimethoxypyrimidin-2-yl)amino]methyl]-2-azabicyclo[3.1.0]hexan-2-yl]-[2-methyl-5-(3-methylphenyl)-1,3-thiazol-4-yl]methanone Chemical compound COC1=CC(OC)=NC(NC[C@H]2N([C@H]3C[C@H]3C2)C(=O)C2=C(SC(C)=N2)C=2C=C(C)C=CC=2)=N1 OCPFLHDEAUPJKB-SQNIBIBYSA-N 0.000 claims 1
- MVPBEYORUDQRHJ-NJAFHUGGSA-N [(1s,3s,5s)-3-[[(5-bromopyrimidin-2-yl)amino]methyl]-2-azabicyclo[3.1.0]hexan-2-yl]-(2-cyclopropyl-5-phenyl-1,3-thiazol-4-yl)methanone Chemical compound N1=CC(Br)=CN=C1NC[C@H]1N(C(=O)C2=C(SC(=N2)C2CC2)C=2C=CC=CC=2)[C@H]2C[C@H]2C1 MVPBEYORUDQRHJ-NJAFHUGGSA-N 0.000 claims 1
- VXSMUGJLHVKIPB-PVAVHDDUSA-N [(1s,3s,5s)-3-[[(5-bromopyrimidin-2-yl)amino]methyl]-2-azabicyclo[3.1.0]hexan-2-yl]-(2-methyl-5-phenyl-1,3-thiazol-4-yl)methanone Chemical compound C([C@@H]1C[C@@H]2C[C@@H]2N1C(=O)C=1N=C(SC=1C=1C=CC=CC=1)C)NC1=NC=C(Br)C=N1 VXSMUGJLHVKIPB-PVAVHDDUSA-N 0.000 claims 1
- JJYPMUVMTCCHFA-NJAFHUGGSA-N [(1s,3s,5s)-3-[[(5-bromopyrimidin-2-yl)amino]methyl]-2-azabicyclo[3.1.0]hexan-2-yl]-[2-methyl-5-(3-methylphenyl)-1,3-thiazol-4-yl]methanone Chemical compound C([C@@H]1C[C@@H]2C[C@@H]2N1C(=O)C=1N=C(SC=1C=1C=C(C)C=CC=1)C)NC1=NC=C(Br)C=N1 JJYPMUVMTCCHFA-NJAFHUGGSA-N 0.000 claims 1
- WSLKOLMTAAYPMR-COXVUDFISA-N [(1s,3s,5s)-3-[[(5-bromopyrimidin-2-yl)amino]methyl]-2-azabicyclo[3.1.0]hexan-2-yl]-[2-methyl-5-[3-(trifluoromethyl)phenyl]-1,3-thiazol-4-yl]methanone Chemical compound C([C@@H]1C[C@@H]2C[C@@H]2N1C(=O)C=1N=C(SC=1C=1C=C(C=CC=1)C(F)(F)F)C)NC1=NC=C(Br)C=N1 WSLKOLMTAAYPMR-COXVUDFISA-N 0.000 claims 1
- UTIODKKMBCLUHW-IFIJOSMWSA-N [(1s,3s,5s)-3-[[(5-bromopyrimidin-2-yl)amino]methyl]-2-azabicyclo[3.1.0]hexan-2-yl]-[5-(3,4-dichlorophenyl)-2-methyl-1,3-thiazol-4-yl]methanone Chemical compound C([C@@H]1C[C@@H]2C[C@@H]2N1C(=O)C=1N=C(SC=1C=1C=C(Cl)C(Cl)=CC=1)C)NC1=NC=C(Br)C=N1 UTIODKKMBCLUHW-IFIJOSMWSA-N 0.000 claims 1
- BEXLHINYFZDODT-IFIJOSMWSA-N [(1s,3s,5s)-3-[[(5-bromopyrimidin-2-yl)amino]methyl]-2-azabicyclo[3.1.0]hexan-2-yl]-[5-(3,4-difluorophenyl)-2-methyl-1,3-thiazol-4-yl]methanone Chemical compound C([C@@H]1C[C@@H]2C[C@@H]2N1C(=O)C=1N=C(SC=1C=1C=C(F)C(F)=CC=1)C)NC1=NC=C(Br)C=N1 BEXLHINYFZDODT-IFIJOSMWSA-N 0.000 claims 1
- ZWCXIYNPZUPTJW-NEWSRXKRSA-N [(1s,3s,5s)-3-[[(5-bromopyrimidin-2-yl)amino]methyl]-2-azabicyclo[3.1.0]hexan-2-yl]-[5-(3,4-dimethylphenyl)-2-methyl-1,3-thiazol-4-yl]methanone Chemical compound C([C@@H]1C[C@@H]2C[C@@H]2N1C(=O)C=1N=C(SC=1C=1C=C(C)C(C)=CC=1)C)NC1=NC=C(Br)C=N1 ZWCXIYNPZUPTJW-NEWSRXKRSA-N 0.000 claims 1
- MNKSTPMLQGTDKD-MNEFBYGVSA-N [(1s,3s,5s)-3-[[(5-bromopyrimidin-2-yl)amino]methyl]-2-azabicyclo[3.1.0]hexan-2-yl]-[5-(3,5-dimethylphenyl)-2-methyl-1,3-thiazol-4-yl]methanone Chemical compound C([C@@H]1C[C@@H]2C[C@@H]2N1C(=O)C=1N=C(SC=1C=1C=C(C)C=C(C)C=1)C)NC1=NC=C(Br)C=N1 MNKSTPMLQGTDKD-MNEFBYGVSA-N 0.000 claims 1
- BVRLEKPFIWDGBN-KCXAZCMYSA-N [(1s,3s,5s)-3-[[(5-bromopyrimidin-2-yl)amino]methyl]-2-azabicyclo[3.1.0]hexan-2-yl]-[5-(3-chlorophenyl)-1,3-thiazol-4-yl]methanone Chemical compound ClC1=CC=CC(C2=C(N=CS2)C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC=2N=CC(Br)=CN=2)=C1 BVRLEKPFIWDGBN-KCXAZCMYSA-N 0.000 claims 1
- NODAGFGTEXFBBV-COXVUDFISA-N [(1s,3s,5s)-3-[[(5-bromopyrimidin-2-yl)amino]methyl]-2-azabicyclo[3.1.0]hexan-2-yl]-[5-(3-chlorophenyl)-2-methyl-1,3-thiazol-4-yl]methanone Chemical compound C([C@@H]1C[C@@H]2C[C@@H]2N1C(=O)C=1N=C(SC=1C=1C=C(Cl)C=CC=1)C)NC1=NC=C(Br)C=N1 NODAGFGTEXFBBV-COXVUDFISA-N 0.000 claims 1
- ULTVXVJJYMVKKB-HFTRVMKXSA-N [(1s,3s,5s)-3-[[(5-bromopyrimidin-2-yl)amino]methyl]-2-azabicyclo[3.1.0]hexan-2-yl]-[5-(3-fluoro-4-methylphenyl)-2-methyl-1,3-thiazol-4-yl]methanone Chemical compound C([C@@H]1C[C@@H]2C[C@@H]2N1C(=O)C=1N=C(SC=1C=1C=C(F)C(C)=CC=1)C)NC1=NC=C(Br)C=N1 ULTVXVJJYMVKKB-HFTRVMKXSA-N 0.000 claims 1
- IHCDQMGOFLPHAI-KMFMINBZSA-N [(1s,3s,5s)-3-[[(5-bromopyrimidin-2-yl)amino]methyl]-2-azabicyclo[3.1.0]hexan-2-yl]-[5-(3-methoxyphenyl)-1,3-thiazol-4-yl]methanone Chemical compound COC1=CC=CC(C2=C(N=CS2)C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC=2N=CC(Br)=CN=2)=C1 IHCDQMGOFLPHAI-KMFMINBZSA-N 0.000 claims 1
- VIRNIFNUAHJGFC-AABGKKOBSA-N [(1s,3s,5s)-3-[[(5-ethylpyrimidin-2-yl)amino]methyl]-2-azabicyclo[3.1.0]hexan-2-yl]-[2-methyl-5-(3-methylphenyl)-1,3-thiazol-4-yl]methanone Chemical compound N1=CC(CC)=CN=C1NC[C@H]1N(C(=O)C2=C(SC(C)=N2)C=2C=C(C)C=CC=2)[C@H]2C[C@H]2C1 VIRNIFNUAHJGFC-AABGKKOBSA-N 0.000 claims 1
- BYJKDVRXONVAPA-IKGGRYGDSA-N [2-methyl-5-(3-methylphenyl)-1,3-thiazol-4-yl]-[(1s,3s,5s)-3-[[[4-(trifluoromethyl)pyrimidin-2-yl]amino]methyl]-2-azabicyclo[3.1.0]hexan-2-yl]methanone Chemical compound C([C@@H]1C[C@@H]2C[C@@H]2N1C(=O)C=1N=C(SC=1C=1C=C(C)C=CC=1)C)NC1=NC=CC(C(F)(F)F)=N1 BYJKDVRXONVAPA-IKGGRYGDSA-N 0.000 claims 1
- 230000002159 abnormal effect Effects 0.000 claims 1
- 230000005856 abnormality Effects 0.000 claims 1
- 208000028311 absence seizure Diseases 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 206010000496 acne Diseases 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 208000005298 acute pain Diseases 0.000 claims 1
- 208000012826 adjustment disease Diseases 0.000 claims 1
- 230000001919 adrenal effect Effects 0.000 claims 1
- 201000007930 alcohol dependence Diseases 0.000 claims 1
- 125000004414 alkyl thio group Chemical group 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 230000007815 allergy Effects 0.000 claims 1
- 206010053552 allodynia Diseases 0.000 claims 1
- 231100000540 amenorrhea Toxicity 0.000 claims 1
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims 1
- 230000036592 analgesia Effects 0.000 claims 1
- 230000036506 anxiety Effects 0.000 claims 1
- 230000036528 appetite Effects 0.000 claims 1
- 235000019789 appetite Nutrition 0.000 claims 1
- 230000006793 arrhythmia Effects 0.000 claims 1
- 206010003119 arrhythmia Diseases 0.000 claims 1
- 230000002917 arthritic effect Effects 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 125000004603 benzisoxazolyl group Chemical group O1N=C(C2=C1C=CC=C2)* 0.000 claims 1
- 125000005605 benzo group Chemical group 0.000 claims 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 208000028683 bipolar I disease Diseases 0.000 claims 1
- 230000000740 bleeding effect Effects 0.000 claims 1
- 208000026106 cerebrovascular disease Diseases 0.000 claims 1
- 238000002512 chemotherapy Methods 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 208000020832 chronic kidney disease Diseases 0.000 claims 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 208000029078 coronary artery disease Diseases 0.000 claims 1
- 208000014826 cranial nerve neuropathy Diseases 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 208000031513 cyst Diseases 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 230000006806 disease prevention Effects 0.000 claims 1
- 235000014632 disordered eating Nutrition 0.000 claims 1
- 208000018459 dissociative disease Diseases 0.000 claims 1
- 208000009985 drug-induced dyskinesia Diseases 0.000 claims 1
- 208000024732 dysthymic disease Diseases 0.000 claims 1
- 206010016165 failure to thrive Diseases 0.000 claims 1
- 230000002496 gastric effect Effects 0.000 claims 1
- 201000005917 gastric ulcer Diseases 0.000 claims 1
- 208000029364 generalized anxiety disease Diseases 0.000 claims 1
- 230000006589 gland dysfunction Effects 0.000 claims 1
- 231100000869 headache Toxicity 0.000 claims 1
- 230000010370 hearing loss Effects 0.000 claims 1
- 231100000888 hearing loss Toxicity 0.000 claims 1
- 208000016354 hearing loss disease Diseases 0.000 claims 1
- 229940088597 hormone Drugs 0.000 claims 1
- 239000005556 hormone Substances 0.000 claims 1
- 208000031424 hyperprolactinemia Diseases 0.000 claims 1
- 230000036031 hyperthermia Effects 0.000 claims 1
- 230000036543 hypotension Effects 0.000 claims 1
- DOGXPDFZEQXZDS-UHFFFAOYSA-N imidazo[1,2-a]pyridine-3-carboxylic acid Chemical compound C1=CC=CN2C(C(=O)O)=CN=C21 DOGXPDFZEQXZDS-UHFFFAOYSA-N 0.000 claims 1
- 125000005946 imidazo[1,2-a]pyridyl group Chemical group 0.000 claims 1
- ZGIABSKPSCMXFD-UHFFFAOYSA-N imidazo[2,1-b][1,3]thiazole-5-carboxylic acid Chemical compound S1C=CN2C(C(=O)O)=CN=C21 ZGIABSKPSCMXFD-UHFFFAOYSA-N 0.000 claims 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims 1
- 125000001041 indolyl group Chemical group 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 208000020658 intracerebral hemorrhage Diseases 0.000 claims 1
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims 1
- 125000000842 isoxazolyl group Chemical group 0.000 claims 1
- 208000033915 jet lag type circadian rhythm sleep disease Diseases 0.000 claims 1
- 201000010982 kidney cancer Diseases 0.000 claims 1
- 208000017169 kidney disease Diseases 0.000 claims 1
- 230000003902 lesion Effects 0.000 claims 1
- 208000024714 major depressive disease Diseases 0.000 claims 1
- 208000030159 metabolic disease Diseases 0.000 claims 1
- 206010027599 migraine Diseases 0.000 claims 1
- 230000036651 mood Effects 0.000 claims 1
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- BBBBXICMCPTHBJ-MSYCTHLASA-N n-[[(1s,3s,5s)-2-(2-methyl-4-phenylpyrimidine-5-carbonyl)-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1-benzofuran-4-carboxamide Chemical compound N=1C(C)=NC=C(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3C=COC=3C=CC=2)C=1C1=CC=CC=C1 BBBBXICMCPTHBJ-MSYCTHLASA-N 0.000 claims 1
- OVOZTIRKTQGQLV-DXIQSLLYSA-N n-[[(1s,3s,5s)-2-(2-methyl-4-phenylpyrimidine-5-carbonyl)-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxamide Chemical compound N=1C(C)=NC=C(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3OCCOC=3C=CC=2)C=1C1=CC=CC=C1 OVOZTIRKTQGQLV-DXIQSLLYSA-N 0.000 claims 1
- IMNKHTQTALTWLQ-URVUXULASA-N n-[[(1s,3s,5s)-2-(2-methyl-5-phenyl-1,3-thiazole-4-carbonyl)-2-azabicyclo[3.1.0]hexan-3-yl]methyl]quinoline-8-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=NC=CC=C3C=CC=2)=C1C1=CC=CC=C1 IMNKHTQTALTWLQ-URVUXULASA-N 0.000 claims 1
- ZXNUBKZHCMLXBK-DPLHUUCSSA-N n-[[(1s,3s,5s)-2-(5-methyl-2-phenylfuran-3-carbonyl)-2-azabicyclo[3.1.0]hexan-3-yl]methyl]quinoline-8-carboxamide Chemical compound O1C(C)=CC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=NC=CC=C3C=CC=2)=C1C1=CC=CC=C1 ZXNUBKZHCMLXBK-DPLHUUCSSA-N 0.000 claims 1
- MVPMCQDMUCLMIY-WIEQDCTASA-N n-[[(1s,3s,5s)-2-[2-(2-amino-1,3-thiazol-4-yl)benzoyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1-benzofuran-4-carboxamide Chemical compound S1C(N)=NC(C=2C(=CC=CC=2)C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3C=COC=3C=CC=2)=C1 MVPMCQDMUCLMIY-WIEQDCTASA-N 0.000 claims 1
- IYRVYLAWVYZPPZ-SIFCLUCFSA-N n-[[(1s,3s,5s)-2-[2-(2-amino-1,3-thiazol-4-yl)benzoyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxamide Chemical compound S1C(N)=NC(C=2C(=CC=CC=2)C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3OCCOC=3C=CC=2)=C1 IYRVYLAWVYZPPZ-SIFCLUCFSA-N 0.000 claims 1
- YORWJYKLNUAMLP-GLJUWKHASA-N n-[[(1s,3s,5s)-2-[2-(2-amino-1,3-thiazol-4-yl)benzoyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-6-methylimidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound N1([C@H]2C[C@H]2C[C@H]1CNC(=O)C=1N2C=CSC2=NC=1C)C(=O)C1=CC=CC=C1C1=CSC(N)=N1 YORWJYKLNUAMLP-GLJUWKHASA-N 0.000 claims 1
- FGCNGGNPMHRAGA-UZEJHQAJSA-N n-[[(1s,3s,5s)-2-[2-(2-fluorophenyl)benzoyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1-benzofuran-4-carboxamide Chemical compound FC1=CC=CC=C1C1=CC=CC=C1C(=O)N1[C@H](CNC(=O)C=2C=3C=COC=3C=CC=2)C[C@@H]2C[C@@H]21 FGCNGGNPMHRAGA-UZEJHQAJSA-N 0.000 claims 1
- UHINWWWQPPBTFJ-AOUJKTHWSA-N n-[[(1s,3s,5s)-2-[2-(3-chlorophenyl)benzoyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1-benzofuran-4-carboxamide Chemical compound ClC1=CC=CC(C=2C(=CC=CC=2)C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3C=COC=3C=CC=2)=C1 UHINWWWQPPBTFJ-AOUJKTHWSA-N 0.000 claims 1
- WRXHACFFYAGOIW-SQNIBIBYSA-N n-[[(1s,3s,5s)-2-[2-(dimethylamino)-5-phenyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-6-methylimidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound S1C(N(C)C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2N3C=CSC3=NC=2C)=C1C1=CC=CC=C1 WRXHACFFYAGOIW-SQNIBIBYSA-N 0.000 claims 1
- VAATUMGPJZOHDP-KMFMINBZSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1,2,3-benzothiadiazole-5-carboxamide Chemical compound S1C(N)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=C3N=NSC3=CC=2)=C1C1=CC=CC(F)=C1 VAATUMGPJZOHDP-KMFMINBZSA-N 0.000 claims 1
- RYZMMEDSLCCAHE-KMFMINBZSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1,2-benzoxazole-3-carboxamide Chemical compound S1C(N)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=CC=CC=C3ON=2)=C1C1=CC=CC(F)=C1 RYZMMEDSLCCAHE-KMFMINBZSA-N 0.000 claims 1
- JOIKNOONRUDGRB-MMOPVJDHSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1,2-dimethylindole-3-carboxamide Chemical compound N1([C@H]2C[C@H]2C[C@H]1CNC(=O)C1=C(N(C2=CC=CC=C21)C)C)C(=O)C=1N=C(N)SC=1C1=CC=CC(F)=C1 JOIKNOONRUDGRB-MMOPVJDHSA-N 0.000 claims 1
- PYBMNLHPXNANJX-PVAVHDDUSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1,3,5-trimethylpyrazole-4-carboxamide Chemical compound CC1=NN(C)C(C)=C1C(=O)NC[C@H]1N(C(=O)C2=C(SC(N)=N2)C=2C=C(F)C=CC=2)[C@H]2C[C@H]2C1 PYBMNLHPXNANJX-PVAVHDDUSA-N 0.000 claims 1
- ZRNCUSLODZTAGF-KMFMINBZSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1,3-benzodioxole-4-carboxamide Chemical compound S1C(N)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3OCOC=3C=CC=2)=C1C1=CC=CC(F)=C1 ZRNCUSLODZTAGF-KMFMINBZSA-N 0.000 claims 1
- KYSRXVHHVYSPTP-KMFMINBZSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1,3-dimethylpyrazole-4-carboxamide Chemical compound CC1=NN(C)C=C1C(=O)NC[C@H]1N(C(=O)C2=C(SC(N)=N2)C=2C=C(F)C=CC=2)[C@H]2C[C@H]2C1 KYSRXVHHVYSPTP-KMFMINBZSA-N 0.000 claims 1
- WRVOIYHUVDVRNE-ALKREAHSSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1-benzofuran-4-carboxamide Chemical compound S1C(N)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3C=COC=3C=CC=2)=C1C1=CC=CC(F)=C1 WRVOIYHUVDVRNE-ALKREAHSSA-N 0.000 claims 1
- FBKAZYQXMOLMMU-HFTRVMKXSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1-ethyl-3-methylpyrazole-4-carboxamide Chemical compound CC1=NN(CC)C=C1C(=O)NC[C@H]1N(C(=O)C2=C(SC(N)=N2)C=2C=C(F)C=CC=2)[C@H]2C[C@H]2C1 FBKAZYQXMOLMMU-HFTRVMKXSA-N 0.000 claims 1
- ADJCWOYNWYOWIM-ZLDLUXBVSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1-methyl-5-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound CN1N=CC(C(=O)NC[C@H]2N([C@H]3C[C@H]3C2)C(=O)C2=C(SC(N)=N2)C=2C=C(F)C=CC=2)=C1C(F)(F)F ADJCWOYNWYOWIM-ZLDLUXBVSA-N 0.000 claims 1
- UDPYNUNNSFKAGE-KUDFPVQQSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1-methylindole-3-carboxamide Chemical compound N1([C@H]2C[C@H]2C[C@H]1CNC(=O)C1=CN(C2=CC=CC=C21)C)C(=O)C=1N=C(N)SC=1C1=CC=CC(F)=C1 UDPYNUNNSFKAGE-KUDFPVQQSA-N 0.000 claims 1
- LISJIDFCWXAONY-XUWXXGDYSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1h-indazole-3-carboxamide Chemical compound S1C(N)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=CC=CC=C3NN=2)=C1C1=CC=CC(F)=C1 LISJIDFCWXAONY-XUWXXGDYSA-N 0.000 claims 1
- KZLZLPNETUUCPZ-IIMJZQEZSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1h-indole-3-carboxamide Chemical compound S1C(N)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=CC=CC=C3NC=2)=C1C1=CC=CC(F)=C1 KZLZLPNETUUCPZ-IIMJZQEZSA-N 0.000 claims 1
- RIVJJZYVIMDNKH-INWMFGNUSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,2-difluoro-1,3-benzodioxole-4-carboxamide Chemical compound S1C(N)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3OC(F)(F)OC=3C=CC=2)=C1C1=CC=CC(F)=C1 RIVJJZYVIMDNKH-INWMFGNUSA-N 0.000 claims 1
- YPLIPLLENOEHFJ-KPFFTGBYSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,2-dimethyl-3h-1-benzofuran-7-carboxamide Chemical compound N1([C@H]2C[C@H]2C[C@H]1CNC(=O)C=1C=CC=C2CC(OC2=1)(C)C)C(=O)C=1N=C(N)SC=1C1=CC=CC(F)=C1 YPLIPLLENOEHFJ-KPFFTGBYSA-N 0.000 claims 1
- FSJQWDJNMKMWGA-HFTRVMKXSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxamide Chemical compound S1C(N)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3OCCOC=3C=CC=2)=C1C1=CC=CC(F)=C1 FSJQWDJNMKMWGA-HFTRVMKXSA-N 0.000 claims 1
- CJTMBFBFOHCHNN-ALKREAHSSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound S1C(N)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3CCOC=3C=CC=2)=C1C1=CC=CC(F)=C1 CJTMBFBFOHCHNN-ALKREAHSSA-N 0.000 claims 1
- SXOUZMVBNPCWIL-KBMXLJTQSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,5-dimethyl-1,3-oxazole-4-carboxamide Chemical compound O1C(C)=NC(C(=O)NC[C@H]2N([C@H]3C[C@H]3C2)C(=O)C2=C(SC(N)=N2)C=2C=C(F)C=CC=2)=C1C SXOUZMVBNPCWIL-KBMXLJTQSA-N 0.000 claims 1
- IHBNXFCVHGTHKD-KBMXLJTQSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,5-dimethylpyrazole-3-carboxamide Chemical compound CN1N=C(C)C=C1C(=O)NC[C@H]1N(C(=O)C2=C(SC(N)=N2)C=2C=C(F)C=CC=2)[C@H]2C[C@H]2C1 IHBNXFCVHGTHKD-KBMXLJTQSA-N 0.000 claims 1
- FFWZFLVTHJRBRH-PVAVHDDUSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2-ethyl-5-methylpyrazole-3-carboxamide Chemical compound CCN1N=C(C)C=C1C(=O)NC[C@H]1N(C(=O)C2=C(SC(N)=N2)C=2C=C(F)C=CC=2)[C@H]2C[C@H]2C1 FFWZFLVTHJRBRH-PVAVHDDUSA-N 0.000 claims 1
- GWZRHORPTRIYPH-KBMXLJTQSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2-methylimidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound N1([C@H]2C[C@H]2C[C@H]1CNC(=O)C=1N2C=C(SC2=NC=1)C)C(=O)C=1N=C(N)SC=1C1=CC=CC(F)=C1 GWZRHORPTRIYPH-KBMXLJTQSA-N 0.000 claims 1
- YQNTXYIXVCDHDS-ALKREAHSSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2-methylindazole-3-carboxamide Chemical compound N1([C@H]2C[C@H]2C[C@H]1CNC(=O)C1=C2C=CC=CC2=NN1C)C(=O)C=1N=C(N)SC=1C1=CC=CC(F)=C1 YQNTXYIXVCDHDS-ALKREAHSSA-N 0.000 claims 1
- WZMUZXOAZRXIOV-KBMXLJTQSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-3,5-dimethyl-1,2-oxazole-4-carboxamide Chemical compound CC1=NOC(C)=C1C(=O)NC[C@H]1N(C(=O)C2=C(SC(N)=N2)C=2C=C(F)C=CC=2)[C@H]2C[C@H]2C1 WZMUZXOAZRXIOV-KBMXLJTQSA-N 0.000 claims 1
- SWHHAPFYDVAOTR-XBFCOCLRSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-3-methyl-5-(trifluoromethyl)-1,2-oxazole-4-carboxamide Chemical compound CC1=NOC(C(F)(F)F)=C1C(=O)NC[C@H]1N(C(=O)C2=C(SC(N)=N2)C=2C=C(F)C=CC=2)[C@H]2C[C@H]2C1 SWHHAPFYDVAOTR-XBFCOCLRSA-N 0.000 claims 1
- ZCPJOEXFIVNBSM-KBMXLJTQSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-3-methylimidazo[2,1-b][1,3]thiazole-2-carboxamide Chemical compound N1([C@H]2C[C@H]2C[C@H]1CNC(=O)C1=C(N2C=CN=C2S1)C)C(=O)C=1N=C(N)SC=1C1=CC=CC(F)=C1 ZCPJOEXFIVNBSM-KBMXLJTQSA-N 0.000 claims 1
- KJPSTUQGVALPNP-KBMXLJTQSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-5-ethyl-3-methyl-1,2-oxazole-4-carboxamide Chemical compound O1N=C(C)C(C(=O)NC[C@H]2N([C@H]3C[C@H]3C2)C(=O)C2=C(SC(N)=N2)C=2C=C(F)C=CC=2)=C1CC KJPSTUQGVALPNP-KBMXLJTQSA-N 0.000 claims 1
- KUNVODKYBAOYPV-BPAFIMBUSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-5-fluoro-1-methylindole-2-carboxamide Chemical compound N1([C@H]2C[C@H]2C[C@H]1CNC(=O)C=1N(C2=CC=C(F)C=C2C=1)C)C(=O)C=1N=C(N)SC=1C1=CC=CC(F)=C1 KUNVODKYBAOYPV-BPAFIMBUSA-N 0.000 claims 1
- QZBPIWQBWWPEHK-PVAVHDDUSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-5-tert-butyl-2-methylpyrazole-3-carboxamide Chemical compound CN1N=C(C(C)(C)C)C=C1C(=O)NC[C@H]1N(C(=O)C2=C(SC(N)=N2)C=2C=C(F)C=CC=2)[C@H]2C[C@H]2C1 QZBPIWQBWWPEHK-PVAVHDDUSA-N 0.000 claims 1
- VDQAGIQIUIZORQ-FMEYXAORSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-6-fluoro-4h-1,3-benzodioxine-8-carboxamide Chemical compound S1C(N)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3OCOCC=3C=C(F)C=2)=C1C1=CC=CC(F)=C1 VDQAGIQIUIZORQ-FMEYXAORSA-N 0.000 claims 1
- DIZQXVPSQFCAJY-KBMXLJTQSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-6-methylimidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound N1([C@H]2C[C@H]2C[C@H]1CNC(=O)C=1N2C=CSC2=NC=1C)C(=O)C=1N=C(N)SC=1C1=CC=CC(F)=C1 DIZQXVPSQFCAJY-KBMXLJTQSA-N 0.000 claims 1
- MUDFTNOBBRYNGR-SNPRPXQTSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound S1C(N)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2N3C=CSC3=NC=2)=C1C1=CC=CC(F)=C1 MUDFTNOBBRYNGR-SNPRPXQTSA-N 0.000 claims 1
- YGIUUAOPOXXRJV-KPFFTGBYSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]isoquinoline-1-carboxamide Chemical compound S1C(N)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=CC=CC=C3C=CN=2)=C1C1=CC=CC(F)=C1 YGIUUAOPOXXRJV-KPFFTGBYSA-N 0.000 claims 1
- FQQGWKSSBLQNSB-MMOPVJDHSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]isoquinoline-5-carboxamide Chemical compound S1C(N)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=CC=NC=C3C=CC=2)=C1C1=CC=CC(F)=C1 FQQGWKSSBLQNSB-MMOPVJDHSA-N 0.000 claims 1
- GYNSFMRWLPIVJD-KUDFPVQQSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]quinoline-4-carboxamide Chemical compound S1C(N)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=CC=CC=C3N=CC=2)=C1C1=CC=CC(F)=C1 GYNSFMRWLPIVJD-KUDFPVQQSA-N 0.000 claims 1
- JKHPJPIOIGQUSW-KUDFPVQQSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]quinoline-5-carboxamide Chemical compound S1C(N)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=CC=CN=C3C=CC=2)=C1C1=CC=CC(F)=C1 JKHPJPIOIGQUSW-KUDFPVQQSA-N 0.000 claims 1
- ICZOTUOVKVXDJS-KPFFTGBYSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]quinoline-8-carboxamide Chemical compound S1C(N)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=NC=CC=C3C=CC=2)=C1C1=CC=CC(F)=C1 ICZOTUOVKVXDJS-KPFFTGBYSA-N 0.000 claims 1
- BJUAUMKZWDEZAL-UWVAXJGDSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1-benzofuran-4-carboxamide Chemical compound CC1=CC=CC(C2=C(N=C(N)S2)C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3C=COC=3C=CC=2)=C1 BJUAUMKZWDEZAL-UWVAXJGDSA-N 0.000 claims 1
- UVTNQXCWIQUOAO-UWVAXJGDSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1-methylindazole-3-carboxamide Chemical compound CC1=CC=CC(C2=C(N=C(N)S2)C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=CC=CC=C3N(C)N=2)=C1 UVTNQXCWIQUOAO-UWVAXJGDSA-N 0.000 claims 1
- JRPGUYFEQYSWLH-AOIWGVFYSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxamide Chemical compound CC1=CC=CC(C2=C(N=C(N)S2)C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3OCCOC=3C=CC=2)=C1 JRPGUYFEQYSWLH-AOIWGVFYSA-N 0.000 claims 1
- NDWOXJJCWNRPHY-UWVAXJGDSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound CC1=CC=CC(C2=C(N=C(N)S2)C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3CCOC=3C=CC=2)=C1 NDWOXJJCWNRPHY-UWVAXJGDSA-N 0.000 claims 1
- LIELRRIIARUVHU-HBFSDRIKSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1-benzofuran-7-carboxamide Chemical compound CC1=CC=CC(C2=C(N=C(N)S2)C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3OCCC=3C=CC=2)=C1 LIELRRIIARUVHU-HBFSDRIKSA-N 0.000 claims 1
- QRJBVPFDEZXYFL-PMPSAXMXSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydrothieno[3,4-b][1,4]dioxine-5-carboxamide Chemical compound CC1=CC=CC(C2=C(N=C(N)S2)C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C2=C3OCCOC3=CS2)=C1 QRJBVPFDEZXYFL-PMPSAXMXSA-N 0.000 claims 1
- CMNKWJKYFWEVJN-AOIWGVFYSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-3,4-dihydro-2h-1,4-benzoxazine-5-carboxamide Chemical compound CC1=CC=CC(C2=C(N=C(N)S2)C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3NCCOC=3C=CC=2)=C1 CMNKWJKYFWEVJN-AOIWGVFYSA-N 0.000 claims 1
- URYSQMOHKJMWQI-NEWSRXKRSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-3-bromobenzamide Chemical compound CC1=CC=CC(C2=C(N=C(N)S2)C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=C(Br)C=CC=2)=C1 URYSQMOHKJMWQI-NEWSRXKRSA-N 0.000 claims 1
- SMSKKKDQSPQPBB-HKBOAZHASA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-3-ethynylbenzamide Chemical compound CC1=CC=CC(C2=C(N=C(N)S2)C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=C(C=CC=2)C#C)=C1 SMSKKKDQSPQPBB-HKBOAZHASA-N 0.000 claims 1
- SFSKTVHOJFMXIW-HBFSDRIKSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-3-methylsulfanylbenzamide Chemical compound CSC1=CC=CC(C(=O)NC[C@H]2N([C@H]3C[C@H]3C2)C(=O)C2=C(SC(N)=N2)C=2C=C(C)C=CC=2)=C1 SFSKTVHOJFMXIW-HBFSDRIKSA-N 0.000 claims 1
- DWTJVHUMWXCHJZ-IKGGRYGDSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-6-methylimidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound N1([C@H]2C[C@H]2C[C@H]1CNC(=O)C=1N2C=CSC2=NC=1C)C(=O)C=1N=C(N)SC=1C1=CC=CC(C)=C1 DWTJVHUMWXCHJZ-IKGGRYGDSA-N 0.000 claims 1
- YLKCKZJWYQIFJX-DYXWJJEUSA-N n-[[(1s,3s,5s)-2-[2-amino-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]quinoline-8-carboxamide Chemical compound CC1=CC=CC(C2=C(N=C(N)S2)C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=NC=CC=C3C=CC=2)=C1 YLKCKZJWYQIFJX-DYXWJJEUSA-N 0.000 claims 1
- DGPQYYMFHNHJFI-JLHGSKIFSA-N n-[[(1s,3s,5s)-2-[2-cyclopropyl-5-(2-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound FC1=CC=CC=C1C1=C(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3CCOC=3C=CC=2)N=C(C2CC2)S1 DGPQYYMFHNHJFI-JLHGSKIFSA-N 0.000 claims 1
- HLQLEGQHWVBEPG-LZNRXBQRSA-N n-[[(1s,3s,5s)-2-[2-cyclopropyl-5-(4-fluorophenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound C1=CC(F)=CC=C1C1=C(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3CCOC=3C=CC=2)N=C(C2CC2)S1 HLQLEGQHWVBEPG-LZNRXBQRSA-N 0.000 claims 1
- YLLSWNPZCFUPRS-LZNRXBQRSA-N n-[[(1s,3s,5s)-2-[2-cyclopropyl-5-[3-(trifluoromethyl)phenyl]-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound FC(F)(F)C1=CC=CC(C2=C(N=C(S2)C2CC2)C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3CCOC=3C=CC=2)=C1 YLLSWNPZCFUPRS-LZNRXBQRSA-N 0.000 claims 1
- VJJRTFROQVBXHH-DXIQSLLYSA-N n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1-benzofuran-4-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3C=COC=3C=CC=2)=C1C1=CC=CC(C)=C1 VJJRTFROQVBXHH-DXIQSLLYSA-N 0.000 claims 1
- OLFCCRPHCVZQSG-DYXWJJEUSA-N n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3OCCOC=3C=CC=2)=C1C1=CC=CC(C)=C1 OLFCCRPHCVZQSG-DYXWJJEUSA-N 0.000 claims 1
- KCOANUKFVBJCKP-DXIQSLLYSA-N n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3CCOC=3C=CC=2)=C1C1=CC=CC(C)=C1 KCOANUKFVBJCKP-DXIQSLLYSA-N 0.000 claims 1
- ZUGBKCDIFFBUIC-SQNIBIBYSA-N n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydrothieno[3,4-b][1,4]dioxine-5-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C2=C3OCCOC3=CS2)=C1C1=CC=CC(C)=C1 ZUGBKCDIFFBUIC-SQNIBIBYSA-N 0.000 claims 1
- PEALOQZNTJHOHY-DYXWJJEUSA-N n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-3,4-dihydro-2h-1,4-benzoxazine-5-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3NCCOC=3C=CC=2)=C1C1=CC=CC(C)=C1 PEALOQZNTJHOHY-DYXWJJEUSA-N 0.000 claims 1
- PBTITHPDWJGISI-QTEQDKRBSA-N n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-3,4-dihydro-2h-chromene-5-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3CCCOC=3C=CC=2)=C1C1=CC=CC(C)=C1 PBTITHPDWJGISI-QTEQDKRBSA-N 0.000 claims 1
- GCMSAOJERLBESS-GIWBLDEGSA-N n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-3,4-dihydro-2h-chromene-8-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3OCCCC=3C=CC=2)=C1C1=CC=CC(C)=C1 GCMSAOJERLBESS-GIWBLDEGSA-N 0.000 claims 1
- SINYBNKIDPMQMD-GIVPXCGWSA-N n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-3-(trifluoromethyl)benzamide Chemical compound C([C@@H]1C[C@@H]2C[C@@H]2N1C(=O)C=1N=C(SC=1C=1C=C(C)C=CC=1)C)NC(=O)C1=CC=CC(C(F)(F)F)=C1 SINYBNKIDPMQMD-GIVPXCGWSA-N 0.000 claims 1
- ATVUJFCDAHNQKA-IKGGRYGDSA-N n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-6-(trifluoromethyl)imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2N3C=CSC3=NC=2C(F)(F)F)=C1C1=CC=CC(C)=C1 ATVUJFCDAHNQKA-IKGGRYGDSA-N 0.000 claims 1
- YQDLDJGYDZSKNF-GIWBLDEGSA-N n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]isoquinoline-1-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=CC=CC=C3C=CN=2)=C1C1=CC=CC(C)=C1 YQDLDJGYDZSKNF-GIWBLDEGSA-N 0.000 claims 1
- TUYNRWXGOHLKKD-DPLHUUCSSA-N n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]quinoline-2-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2N=C3C=CC=CC3=CC=2)=C1C1=CC=CC(C)=C1 TUYNRWXGOHLKKD-DPLHUUCSSA-N 0.000 claims 1
- HKBPOHZBBPDWEE-GIWBLDEGSA-N n-[[(1s,3s,5s)-2-[2-methyl-5-(3-methylphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]quinoline-8-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=NC=CC=C3C=CC=2)=C1C1=CC=CC(C)=C1 HKBPOHZBBPDWEE-GIWBLDEGSA-N 0.000 claims 1
- CDJYZBZDMPVNPM-XFQAVAEZSA-N n-[[(1s,3s,5s)-2-[2-methyl-5-[2-(trifluoromethyl)phenyl]-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1-benzofuran-4-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3C=COC=3C=CC=2)=C1C1=CC=CC=C1C(F)(F)F CDJYZBZDMPVNPM-XFQAVAEZSA-N 0.000 claims 1
- FKOJPPYIJVVNNM-GUXCAODWSA-N n-[[(1s,3s,5s)-2-[2-methyl-5-[2-(trifluoromethyl)phenyl]-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3OCCOC=3C=CC=2)=C1C1=CC=CC=C1C(F)(F)F FKOJPPYIJVVNNM-GUXCAODWSA-N 0.000 claims 1
- LRBPYXXOWQPIQY-CBQOVEMMSA-N n-[[(1s,3s,5s)-2-[2-methyl-5-[3-(trifluoromethyl)phenyl]-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]quinoline-8-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=NC=CC=C3C=CC=2)=C1C1=CC=CC(C(F)(F)F)=C1 LRBPYXXOWQPIQY-CBQOVEMMSA-N 0.000 claims 1
- KJGPKBFNTWFXIY-WWMYMODYSA-N n-[[(1s,3s,5s)-2-[5-(2,3-dichlorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]quinoline-8-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=NC=CC=C3C=CC=2)=C1C1=CC=CC(Cl)=C1Cl KJGPKBFNTWFXIY-WWMYMODYSA-N 0.000 claims 1
- GFZBQTVLLBULSP-DPLHUUCSSA-N n-[[(1s,3s,5s)-2-[5-(2,3-dimethylphenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]quinoline-8-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=NC=CC=C3C=CC=2)=C1C1=CC=CC(C)=C1C GFZBQTVLLBULSP-DPLHUUCSSA-N 0.000 claims 1
- RRLLDPBLZSIRIN-GJYPPUQNSA-N n-[[(1s,3s,5s)-2-[5-(3,4-dichlorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2N3C=CC=CC3=NC=2)=C1C1=CC=C(Cl)C(Cl)=C1 RRLLDPBLZSIRIN-GJYPPUQNSA-N 0.000 claims 1
- IRKPOWMQKJCWJT-FGSXEWAUSA-N n-[[(1s,3s,5s)-2-[5-(3,4-dichlorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]quinoline-8-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=NC=CC=C3C=CC=2)=C1C1=CC=C(Cl)C(Cl)=C1 IRKPOWMQKJCWJT-FGSXEWAUSA-N 0.000 claims 1
- RZISYTTYCMGRIV-XFQAVAEZSA-N n-[[(1s,3s,5s)-2-[5-(3,4-difluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3CCOC=3C=CC=2)=C1C1=CC=C(F)C(F)=C1 RZISYTTYCMGRIV-XFQAVAEZSA-N 0.000 claims 1
- AZDXLOMUOCNXEW-FGSXEWAUSA-N n-[[(1s,3s,5s)-2-[5-(3,4-difluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]quinoline-8-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=NC=CC=C3C=CC=2)=C1C1=CC=C(F)C(F)=C1 AZDXLOMUOCNXEW-FGSXEWAUSA-N 0.000 claims 1
- GUKRKVDEZFQTSH-QTEQDKRBSA-N n-[[(1s,3s,5s)-2-[5-(3,4-dimethylphenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3CCOC=3C=CC=2)=C1C1=CC=C(C)C(C)=C1 GUKRKVDEZFQTSH-QTEQDKRBSA-N 0.000 claims 1
- KZQZKNMOTAMKQF-HKBOAZHASA-N n-[[(1s,3s,5s)-2-[5-(3,4-dimethylphenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2N3C=CC=CC3=NC=2)=C1C1=CC=C(C)C(C)=C1 KZQZKNMOTAMKQF-HKBOAZHASA-N 0.000 claims 1
- QCPQDWCUHPQQOM-GPXNEJASSA-N n-[[(1s,3s,5s)-2-[5-(3,4-dimethylphenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]quinoline-8-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=NC=CC=C3C=CC=2)=C1C1=CC=C(C)C(C)=C1 QCPQDWCUHPQQOM-GPXNEJASSA-N 0.000 claims 1
- YDFURXOYOVOKJD-SFLYRZDNSA-N n-[[(1s,3s,5s)-2-[5-(3,5-dimethylphenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]quinoline-8-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=NC=CC=C3C=CC=2)=C1C1=CC(C)=CC(C)=C1 YDFURXOYOVOKJD-SFLYRZDNSA-N 0.000 claims 1
- FEPGFYIHJOPNSL-XFQAVAEZSA-N n-[[(1s,3s,5s)-2-[5-(3-bromo-4-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3CCOC=3C=CC=2)=C1C1=CC=C(F)C(Br)=C1 FEPGFYIHJOPNSL-XFQAVAEZSA-N 0.000 claims 1
- JOHGJYPTRQGDGY-GJYPPUQNSA-N n-[[(1s,3s,5s)-2-[5-(3-bromo-4-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2N3C=CC=CC3=NC=2)=C1C1=CC=C(F)C(Br)=C1 JOHGJYPTRQGDGY-GJYPPUQNSA-N 0.000 claims 1
- ZUEMLXNMUXNLOR-NEWSRXKRSA-N n-[[(1s,3s,5s)-2-[5-(3-chlorophenyl)-2-ethoxy-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound S1C(OCC)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2N3C=CC=CC3=NC=2)=C1C1=CC=CC(Cl)=C1 ZUEMLXNMUXNLOR-NEWSRXKRSA-N 0.000 claims 1
- XUHKGEPMDCAIRN-AYBZRNKSSA-N n-[[(1s,3s,5s)-2-[5-(3-chlorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1,2-benzoxazole-3-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=CC=CC=C3ON=2)=C1C1=CC=CC(Cl)=C1 XUHKGEPMDCAIRN-AYBZRNKSSA-N 0.000 claims 1
- KULMNBBOQJYNOV-RFWXGWTQSA-N n-[[(1s,3s,5s)-2-[5-(3-chlorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1,2-dimethylindole-3-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=CC=CC=C3N(C)C=2C)=C1C1=CC=CC(Cl)=C1 KULMNBBOQJYNOV-RFWXGWTQSA-N 0.000 claims 1
- MZVIWUMTFZWTSC-KPFFTGBYSA-N n-[[(1s,3s,5s)-2-[5-(3-chlorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1-ethyl-3-methylpyrazole-4-carboxamide Chemical compound CC1=NN(CC)C=C1C(=O)NC[C@H]1N(C(=O)C2=C(SC(C)=N2)C=2C=C(Cl)C=CC=2)[C@H]2C[C@H]2C1 MZVIWUMTFZWTSC-KPFFTGBYSA-N 0.000 claims 1
- DLOVGCVIGXHUNF-SYNHAJSKSA-N n-[[(1s,3s,5s)-2-[5-(3-chlorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1h-indazole-3-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=CC=CC=C3NN=2)=C1C1=CC=CC(Cl)=C1 DLOVGCVIGXHUNF-SYNHAJSKSA-N 0.000 claims 1
- YIXBQPFPRXJUDG-NRJQMVOHSA-N n-[[(1s,3s,5s)-2-[5-(3-chlorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1h-indole-3-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=CC=CC=C3NC=2)=C1C1=CC=CC(Cl)=C1 YIXBQPFPRXJUDG-NRJQMVOHSA-N 0.000 claims 1
- ZHSWDDMSCPEKSE-KPFFTGBYSA-N n-[[(1s,3s,5s)-2-[5-(3-chlorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3OCCOC=3C=CC=2)=C1C1=CC=CC(Cl)=C1 ZHSWDDMSCPEKSE-KPFFTGBYSA-N 0.000 claims 1
- PJJFOLAESAPRLI-MMOPVJDHSA-N n-[[(1s,3s,5s)-2-[5-(3-chlorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3CCOC=3C=CC=2)=C1C1=CC=CC(Cl)=C1 PJJFOLAESAPRLI-MMOPVJDHSA-N 0.000 claims 1
- ZWCAZXXGONPGFK-PVAVHDDUSA-N n-[[(1s,3s,5s)-2-[5-(3-chlorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydrothieno[3,4-b][1,4]dioxine-5-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C2=C3OCCOC3=CS2)=C1C1=CC=CC(Cl)=C1 ZWCAZXXGONPGFK-PVAVHDDUSA-N 0.000 claims 1
- YPFFTZMAJGPYGI-NJAFHUGGSA-N n-[[(1s,3s,5s)-2-[5-(3-chlorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,5-dimethylpyrazole-3-carboxamide Chemical compound CN1N=C(C)C=C1C(=O)NC[C@H]1N(C(=O)C2=C(SC(C)=N2)C=2C=C(Cl)C=CC=2)[C@H]2C[C@H]2C1 YPFFTZMAJGPYGI-NJAFHUGGSA-N 0.000 claims 1
- KBSSVCYUMROVTM-NEWSRXKRSA-N n-[[(1s,3s,5s)-2-[5-(3-chlorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2-ethyl-5-methylpyrazole-3-carboxamide Chemical compound CCN1N=C(C)C=C1C(=O)NC[C@H]1N(C(=O)C2=C(SC(C)=N2)C=2C=C(Cl)C=CC=2)[C@H]2C[C@H]2C1 KBSSVCYUMROVTM-NEWSRXKRSA-N 0.000 claims 1
- WWIBMKSHGULDKS-UXPWSPDFSA-N n-[[(1s,3s,5s)-2-[5-(3-chlorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-3-(trifluoromethyl)benzamide Chemical compound C([C@@H]1C[C@@H]2C[C@@H]2N1C(=O)C=1N=C(SC=1C=1C=C(Cl)C=CC=1)C)NC(=O)C1=CC=CC(C(F)(F)F)=C1 WWIBMKSHGULDKS-UXPWSPDFSA-N 0.000 claims 1
- CCEVMRIFKIBBST-LMNJBCLMSA-N n-[[(1s,3s,5s)-2-[5-(3-chlorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-3-methoxybenzamide Chemical compound COC1=CC=CC(C(=O)NC[C@H]2N([C@H]3C[C@H]3C2)C(=O)C2=C(SC(C)=N2)C=2C=C(Cl)C=CC=2)=C1 CCEVMRIFKIBBST-LMNJBCLMSA-N 0.000 claims 1
- WVEYOGBDDMVQGW-NJAFHUGGSA-N n-[[(1s,3s,5s)-2-[5-(3-chlorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-3-methylimidazo[2,1-b][1,3]thiazole-2-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C2=C(N3C=CN=C3S2)C)=C1C1=CC=CC(Cl)=C1 WVEYOGBDDMVQGW-NJAFHUGGSA-N 0.000 claims 1
- AQHMWVQEGIXGRB-AGHHOFFYSA-N n-[[(1s,3s,5s)-2-[5-(3-chlorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-5-fluoro-1-methylindole-2-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2N(C3=CC=C(F)C=C3C=2)C)=C1C1=CC=CC(Cl)=C1 AQHMWVQEGIXGRB-AGHHOFFYSA-N 0.000 claims 1
- ABAFUSICQAJYHX-JJXUHFIVSA-N n-[[(1s,3s,5s)-2-[5-(3-chlorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-6-fluoro-4h-1,3-benzodioxine-8-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3OCOCC=3C=C(F)C=2)=C1C1=CC=CC(Cl)=C1 ABAFUSICQAJYHX-JJXUHFIVSA-N 0.000 claims 1
- AMRUTJGNGLZLAU-NEWSRXKRSA-N n-[[(1s,3s,5s)-2-[5-(3-chlorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2N3C=CC=CC3=NC=2)=C1C1=CC=CC(Cl)=C1 AMRUTJGNGLZLAU-NEWSRXKRSA-N 0.000 claims 1
- PYLPTCXZFSJPBQ-CBQOVEMMSA-N n-[[(1s,3s,5s)-2-[5-(3-chlorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]isoquinoline-1-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=CC=CC=C3C=CN=2)=C1C1=CC=CC(Cl)=C1 PYLPTCXZFSJPBQ-CBQOVEMMSA-N 0.000 claims 1
- LMXRJZBZNFHGQO-RFWXGWTQSA-N n-[[(1s,3s,5s)-2-[5-(3-chlorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]quinoline-2-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2N=C3C=CC=CC3=CC=2)=C1C1=CC=CC(Cl)=C1 LMXRJZBZNFHGQO-RFWXGWTQSA-N 0.000 claims 1
- NUEKDPUEOHJGRL-CBQOVEMMSA-N n-[[(1s,3s,5s)-2-[5-(3-chlorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]quinoline-8-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=NC=CC=C3C=CC=2)=C1C1=CC=CC(Cl)=C1 NUEKDPUEOHJGRL-CBQOVEMMSA-N 0.000 claims 1
- TVEAFQUZIZCOLS-JLHGSKIFSA-N n-[[(1s,3s,5s)-2-[5-(3-fluoro-2-methylphenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3CCOC=3C=CC=2)=C1C1=CC=CC(F)=C1C TVEAFQUZIZCOLS-JLHGSKIFSA-N 0.000 claims 1
- FAELKWNVFKPZTI-AYBZRNKSSA-N n-[[(1s,3s,5s)-2-[5-(3-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1,2,3-benzothiadiazole-5-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=C3N=NSC3=CC=2)=C1C1=CC=CC(F)=C1 FAELKWNVFKPZTI-AYBZRNKSSA-N 0.000 claims 1
- HAEZTYREHPHRFS-AYBZRNKSSA-N n-[[(1s,3s,5s)-2-[5-(3-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1,2-benzoxazole-3-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=CC=CC=C3ON=2)=C1C1=CC=CC(F)=C1 HAEZTYREHPHRFS-AYBZRNKSSA-N 0.000 claims 1
- NWDDGUMPWCBBKH-RFWXGWTQSA-N n-[[(1s,3s,5s)-2-[5-(3-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1,2-dimethylindole-3-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=CC=CC=C3N(C)C=2C)=C1C1=CC=CC(F)=C1 NWDDGUMPWCBBKH-RFWXGWTQSA-N 0.000 claims 1
- RUNJGURNLBVIFZ-AYBZRNKSSA-N n-[[(1s,3s,5s)-2-[5-(3-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1,3-benzodioxole-4-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3OCOC=3C=CC=2)=C1C1=CC=CC(F)=C1 RUNJGURNLBVIFZ-AYBZRNKSSA-N 0.000 claims 1
- IXZDFZYIRMITCC-MMOPVJDHSA-N n-[[(1s,3s,5s)-2-[5-(3-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1-benzofuran-4-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3C=COC=3C=CC=2)=C1C1=CC=CC(F)=C1 IXZDFZYIRMITCC-MMOPVJDHSA-N 0.000 claims 1
- ZWPHKCYSAULFQP-KMFMINBZSA-N n-[[(1s,3s,5s)-2-[5-(3-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1-methyl-5-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound C([C@@H]1C[C@@H]2C[C@@H]2N1C(=O)C=1N=C(SC=1C=1C=C(F)C=CC=1)C)NC(=O)C=1C=NN(C)C=1C(F)(F)F ZWPHKCYSAULFQP-KMFMINBZSA-N 0.000 claims 1
- GPEXRUVIDUNSOK-FHJLPGHOSA-N n-[[(1s,3s,5s)-2-[5-(3-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1-methylindole-3-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=CC=CC=C3N(C)C=2)=C1C1=CC=CC(F)=C1 GPEXRUVIDUNSOK-FHJLPGHOSA-N 0.000 claims 1
- ZAKYHOCPQDNYNQ-SYNHAJSKSA-N n-[[(1s,3s,5s)-2-[5-(3-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1h-indazole-3-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=CC=CC=C3NN=2)=C1C1=CC=CC(F)=C1 ZAKYHOCPQDNYNQ-SYNHAJSKSA-N 0.000 claims 1
- RANNBCIGXQEKKB-CBQOVEMMSA-N n-[[(1s,3s,5s)-2-[5-(3-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,2-dimethyl-3h-1-benzofuran-7-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3OC(C)(C)CC=3C=CC=2)=C1C1=CC=CC(F)=C1 RANNBCIGXQEKKB-CBQOVEMMSA-N 0.000 claims 1
- OCWKZYWPKWZHHI-KPFFTGBYSA-N n-[[(1s,3s,5s)-2-[5-(3-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3OCCOC=3C=CC=2)=C1C1=CC=CC(F)=C1 OCWKZYWPKWZHHI-KPFFTGBYSA-N 0.000 claims 1
- IRSZGAWQARVDBB-MMOPVJDHSA-N n-[[(1s,3s,5s)-2-[5-(3-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3CCOC=3C=CC=2)=C1C1=CC=CC(F)=C1 IRSZGAWQARVDBB-MMOPVJDHSA-N 0.000 claims 1
- LFQJYLUTKWNOSL-NJAFHUGGSA-N n-[[(1s,3s,5s)-2-[5-(3-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,5-dimethylpyrazole-3-carboxamide Chemical compound CN1N=C(C)C=C1C(=O)NC[C@H]1N(C(=O)C2=C(SC(C)=N2)C=2C=C(F)C=CC=2)[C@H]2C[C@H]2C1 LFQJYLUTKWNOSL-NJAFHUGGSA-N 0.000 claims 1
- HDTURWYGRJKUDY-NJAFHUGGSA-N n-[[(1s,3s,5s)-2-[5-(3-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-6-methylimidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2N3C=CSC3=NC=2C)=C1C1=CC=CC(F)=C1 HDTURWYGRJKUDY-NJAFHUGGSA-N 0.000 claims 1
- YADRBPJUUYWGHU-PVAVHDDUSA-N n-[[(1s,3s,5s)-2-[5-(3-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]imidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2N3C=CSC3=NC=2)=C1C1=CC=CC(F)=C1 YADRBPJUUYWGHU-PVAVHDDUSA-N 0.000 claims 1
- LZOWHENTMXNRQV-CBQOVEMMSA-N n-[[(1s,3s,5s)-2-[5-(3-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]isoquinoline-1-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=CC=CC=C3C=CN=2)=C1C1=CC=CC(F)=C1 LZOWHENTMXNRQV-CBQOVEMMSA-N 0.000 claims 1
- LUJFBPBYVPGEBN-RFWXGWTQSA-N n-[[(1s,3s,5s)-2-[5-(3-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]quinoline-2-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2N=C3C=CC=CC3=CC=2)=C1C1=CC=CC(F)=C1 LUJFBPBYVPGEBN-RFWXGWTQSA-N 0.000 claims 1
- ONUYRECGXUHPRC-WWMYMODYSA-N n-[[(1s,3s,5s)-2-[5-(3-methoxyphenyl)-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound COC1=CC=CC(C2=C(N=CS2)C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3CCOC=3C=CC=2)=C1 ONUYRECGXUHPRC-WWMYMODYSA-N 0.000 claims 1
- PXUCQWLVQLBNHW-MMOPVJDHSA-N n-[[(1s,3s,5s)-2-[5-(4-bromophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3CCOC=3C=CC=2)=C1C1=CC=C(Br)C=C1 PXUCQWLVQLBNHW-MMOPVJDHSA-N 0.000 claims 1
- PPHGLFPIIJAYAF-CBQOVEMMSA-N n-[[(1s,3s,5s)-2-[5-(4-bromophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]quinoline-8-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=NC=CC=C3C=CC=2)=C1C1=CC=C(Br)C=C1 PPHGLFPIIJAYAF-CBQOVEMMSA-N 0.000 claims 1
- XPTLYHMSWYFQEP-MMOPVJDHSA-N n-[[(1s,3s,5s)-2-[5-(4-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-1-benzofuran-4-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3C=COC=3C=CC=2)=C1C1=CC=C(F)C=C1 XPTLYHMSWYFQEP-MMOPVJDHSA-N 0.000 claims 1
- AZHMNKZIDLMFPF-KPFFTGBYSA-N n-[[(1s,3s,5s)-2-[5-(4-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3OCCOC=3C=CC=2)=C1C1=CC=C(F)C=C1 AZHMNKZIDLMFPF-KPFFTGBYSA-N 0.000 claims 1
- QKZBDFUUEJARFX-MMOPVJDHSA-N n-[[(1s,3s,5s)-2-[5-(4-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3CCOC=3C=CC=2)=C1C1=CC=C(F)C=C1 QKZBDFUUEJARFX-MMOPVJDHSA-N 0.000 claims 1
- DKKXPZIUGBKRPG-NJAFHUGGSA-N n-[[(1s,3s,5s)-2-[5-(4-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-6-methylimidazo[2,1-b][1,3]thiazole-5-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2N3C=CSC3=NC=2C)=C1C1=CC=C(F)C=C1 DKKXPZIUGBKRPG-NJAFHUGGSA-N 0.000 claims 1
- BCXPFLWKUBVZJM-CBQOVEMMSA-N n-[[(1s,3s,5s)-2-[5-(4-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]quinoline-8-carboxamide Chemical compound S1C(C)=NC(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C3=NC=CC=C3C=CC=2)=C1C1=CC=C(F)C=C1 BCXPFLWKUBVZJM-CBQOVEMMSA-N 0.000 claims 1
- JUBVRLXHQKTHJC-UWVAXJGDSA-N n-[[(1s,3s,5s)-2-[5-(4-methoxyphenyl)-1,3-oxazole-4-carbonyl]-2-azabicyclo[3.1.0]hexan-3-yl]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxamide Chemical compound C1=CC(OC)=CC=C1C1=C(C(=O)N2[C@@H](C[C@@H]3C[C@@H]32)CNC(=O)C=2C=3OCCOC=3C=CC=2)N=CO1 JUBVRLXHQKTHJC-UWVAXJGDSA-N 0.000 claims 1
- 201000003631 narcolepsy Diseases 0.000 claims 1
- 239000004081 narcotic agent Substances 0.000 claims 1
- 230000008693 nausea Effects 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
- 108060005714 orexin Proteins 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 125000002971 oxazolyl group Chemical group 0.000 claims 1
- 208000027753 pain disease Diseases 0.000 claims 1
- 230000008533 pain sensitivity Effects 0.000 claims 1
- 208000019906 panic disease Diseases 0.000 claims 1
- 208000030062 persistent idiopathic facial pain Diseases 0.000 claims 1
- 208000022821 personality disease Diseases 0.000 claims 1
- 208000017402 pituitary gland disease Diseases 0.000 claims 1
- 208000028173 post-traumatic stress disease Diseases 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 201000009395 primary hyperaldosteronism Diseases 0.000 claims 1
- 208000030153 prolactin-producing pituitary gland adenoma Diseases 0.000 claims 1
- 230000001107 psychogenic effect Effects 0.000 claims 1
- 125000003226 pyrazolyl group Chemical group 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- SWVBPJMJJQONPB-UHFFFAOYSA-N pyrrolo[2,1-b][1,3]thiazole-7-carboxylic acid Chemical compound C1=CSC2=C(C(=O)O)C=CN21 SWVBPJMJJQONPB-UHFFFAOYSA-N 0.000 claims 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 1
- 230000004043 responsiveness Effects 0.000 claims 1
- 210000001732 sebaceous gland Anatomy 0.000 claims 1
- 238000005204 segregation Methods 0.000 claims 1
- 230000001953 sensory effect Effects 0.000 claims 1
- 201000002859 sleep apnea Diseases 0.000 claims 1
- 208000019116 sleep disease Diseases 0.000 claims 1
- 210000000278 spinal cord Anatomy 0.000 claims 1
- 208000020431 spinal cord injury Diseases 0.000 claims 1
- 230000002269 spontaneous effect Effects 0.000 claims 1
- 230000035882 stress Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 235000019669 taste disorders Nutrition 0.000 claims 1
- 125000001113 thiadiazolyl group Chemical group 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- 231100000886 tinnitus Toxicity 0.000 claims 1
- 208000004371 toothache Diseases 0.000 claims 1
- 231100000331 toxic Toxicity 0.000 claims 1
- 230000002588 toxic effect Effects 0.000 claims 1
- 230000001052 transient effect Effects 0.000 claims 1
- 230000008733 trauma Effects 0.000 claims 1
- 230000000472 traumatic effect Effects 0.000 claims 1
- SMBZJSVIKJMSFP-UHFFFAOYSA-N trifluoromethyl hypofluorite Chemical compound FOC(F)(F)F SMBZJSVIKJMSFP-UHFFFAOYSA-N 0.000 claims 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 1
- 208000009935 visceral pain Diseases 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB2006055042 | 2006-12-28 | ||
| PCT/IB2007/055326 WO2008081399A2 (en) | 2006-12-28 | 2007-12-28 | 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010514751A JP2010514751A (ja) | 2010-05-06 |
| JP2010514751A5 true JP2010514751A5 (enExample) | 2011-02-17 |
Family
ID=39343649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009543566A Pending JP2010514751A (ja) | 2006-12-28 | 2007-12-28 | オレキシン受容体拮抗薬としての2−アザ−ビシクロ[3.1.0]ヘキサン誘導体 |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US8288435B2 (enExample) |
| EP (1) | EP2094690B1 (enExample) |
| JP (1) | JP2010514751A (enExample) |
| KR (1) | KR20090094168A (enExample) |
| CN (1) | CN101568536B (enExample) |
| AR (1) | AR064561A1 (enExample) |
| AT (1) | ATE505467T1 (enExample) |
| AU (1) | AU2007340944B2 (enExample) |
| BR (1) | BRPI0720876A2 (enExample) |
| CA (1) | CA2669821A1 (enExample) |
| CL (1) | CL2007003827A1 (enExample) |
| CY (1) | CY1111705T1 (enExample) |
| DE (1) | DE602007013937D1 (enExample) |
| DK (1) | DK2094690T3 (enExample) |
| ES (1) | ES2364297T3 (enExample) |
| HR (1) | HRP20110509T1 (enExample) |
| MA (1) | MA31000B1 (enExample) |
| MX (1) | MX2009006860A (enExample) |
| MY (1) | MY157344A (enExample) |
| NO (1) | NO20092762L (enExample) |
| NZ (1) | NZ578642A (enExample) |
| PL (1) | PL2094690T3 (enExample) |
| PT (1) | PT2094690E (enExample) |
| RU (1) | RU2460732C2 (enExample) |
| SI (1) | SI2094690T1 (enExample) |
| TW (1) | TW200833328A (enExample) |
| WO (1) | WO2008081399A2 (enExample) |
| ZA (1) | ZA200905229B (enExample) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2079690B1 (en) * | 2006-09-29 | 2010-09-15 | Actelion Pharmaceuticals Ltd. | 3-aza-bicyclo[3.1.0]hexane derivatives |
| WO2008065626A2 (en) | 2006-12-01 | 2008-06-05 | Actelion Pharmaceuticals Ltd | 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperidine derivativesas orexin receptor inhibitors |
| CL2008000836A1 (es) * | 2007-03-26 | 2008-11-07 | Actelion Pharmaceuticals Ltd | Compuestos derivados de tiazolidina, antagonistas del receptor de orexina; composicion farmaceutica que los comprende; y su uso en el tratamiento de neurosis emocional, depresion grave, trastornos psicoticos, alzheimer, parkinson, dolor, entre otras. |
| US8030495B2 (en) | 2007-05-23 | 2011-10-04 | Coleman Paul J | Cyclopropyl pyrrolidine orexin receptor antagonists |
| EP2207778A2 (en) * | 2007-09-24 | 2010-07-21 | Actelion Pharmaceuticals Ltd. | Pyrrolidines and piperidines as orexin receptor antagonists |
| NZ588080A (en) * | 2008-02-21 | 2012-04-27 | Actelion Pharmaceuticals Ltd | 2-Aza-bicyclo[2.2.1]heptane derivatives |
| CA2722347A1 (en) * | 2008-04-30 | 2009-11-05 | Actelion Pharmaceuticals Ltd | Piperidine and pyrrolidine compounds |
| AU2009305005A1 (en) * | 2008-10-14 | 2010-04-22 | Actelion Pharmaceuticals Ltd | Phenethylamide derivatives and their heterocyclic analogues |
| EP2275421A1 (en) * | 2009-07-15 | 2011-01-19 | Rottapharm S.p.A. | Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction |
| MX2012006909A (es) * | 2009-12-29 | 2012-07-10 | Suven Life Sciences Ltd | LIGANDOS DEL RECEPTOR NICOTINICO NEURONAL A4ß2 DE ACETILCOLINA. |
| MY160969A (en) * | 2010-09-22 | 2017-03-31 | Eisai R&D Man Co Ltd | Cyclopropane compounds |
| US9012489B2 (en) * | 2011-08-03 | 2015-04-21 | Boehringer Ingelheim International Gmbh | Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament |
| WO2013050938A1 (en) | 2011-10-04 | 2013-04-11 | Actelion Pharmaceuticals Ltd | 3,7-diazabicyclo[3.3.1]nonane and 9-oxa-3,7-diazabicyclo[3.3.1]nonane derivatives |
| ITMI20112329A1 (it) * | 2011-12-21 | 2013-06-22 | Rottapharm Spa | Nuovi derivati spiro amminici |
| EP2811997B1 (en) | 2012-02-07 | 2018-04-11 | Eolas Therapeutics Inc. | Substituted prolines/piperidines as orexin receptor antagonists |
| US9440982B2 (en) | 2012-02-07 | 2016-09-13 | Eolas Therapeutics, Inc. | Substituted prolines/piperidines as orexin receptor antagonists |
| ITMI20120424A1 (it) | 2012-03-19 | 2013-09-20 | Rottapharm Spa | Composti chimici |
| LT2855453T (lt) | 2012-06-04 | 2017-02-27 | Actelion Pharmaceuticals Ltd. | Benzimidazolo prolino dariniai |
| CA2879460C (en) * | 2012-07-18 | 2021-10-19 | Garrett MORASKI | 5,5-heteroaromatic anti-infective compounds |
| US9493446B2 (en) | 2012-10-10 | 2016-11-15 | Actelion Pharmaceuticals Ltd. | Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives |
| EP2970241A1 (en) | 2013-03-12 | 2016-01-20 | Actelion Pharmaceuticals Ltd. | Azetidine amide derivatives as orexin receptor antagonists |
| TWI621618B (zh) | 2013-03-13 | 2018-04-21 | 比利時商健生藥品公司 | 經取代2-氮雜雙環類及其作為食慾素受體調控劑之用途 |
| TW201444821A (zh) | 2013-03-13 | 2014-12-01 | Janssen Pharmaceutica Nv | 經取代之哌啶化合物及其作為食慾素受體調節劑之用途 |
| TW201444849A (zh) | 2013-03-13 | 2014-12-01 | Janssen Pharmaceutica Nv | 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途 |
| PT3077389T (pt) | 2013-12-03 | 2017-12-15 | Idorsia Pharmaceuticals Ltd | Forma cristalina de (s)-(2-(6-cloro-7-metil-1hbenzo[d]imidazol-2-il)-2-metilpirrolidin-1-il)(5-metoxi-2-(2h-1,2,3-triazol-2-il)fenil)metanona e a sua utilização como como antagonistas do receptor de orexina |
| UA119151C2 (uk) | 2013-12-03 | 2019-05-10 | Ідорсія Фармасьютікалз Лтд | КРИСТАЛІЧНА СОЛЬОВА ФОРМА (S)-(2-(6-ХЛОР-7-МЕТИЛ-1H-БЕНЗО[d]ІМІДАЗОЛ-2-ІЛ)-2-МЕТИЛПІРОЛІДИН-1-ІЛ)(5-МЕТОКСИ-2-(2H-1,2,3-ТРИАЗОЛ-2-ІЛ)ФЕНІЛ)МЕТАНОНУ ЯК АНТАГОНІСТ ОРЕКСИНОВОГО РЕЦЕПТОРА |
| SI3077391T1 (sl) | 2013-12-04 | 2018-11-30 | Idorsia Pharmaceuticals Ltd | Uporaba benzimidazol-prolinskih derivatov |
| TW201613864A (en) | 2014-02-20 | 2016-04-16 | Takeda Pharmaceutical | Novel compounds |
| WO2016025669A1 (en) | 2014-08-13 | 2016-02-18 | Eolas Therapeutics, Inc. | Difluoropyrrolidines as orexin receptor modulators |
| WO2016040789A1 (en) | 2014-09-11 | 2016-03-17 | Janssen Pharmaceutica Nv | Substituted 2-azabicycles and their use as orexin receptor modulators |
| RU2703297C2 (ru) | 2014-10-23 | 2019-10-16 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Композиции и способы для лечения бессонницы |
| CN106588900A (zh) * | 2015-10-20 | 2017-04-26 | 北京康辰医药科技有限公司 | 一种苯并双环化合物或其药学上可接受的盐、药物组合物及其应用 |
| PL3414241T3 (pl) | 2016-02-12 | 2022-10-03 | Astrazeneca Ab | Piperydyny podstawione halo jako modulatory receptora oreksyny |
| BR112018016983A2 (pt) * | 2016-02-26 | 2018-12-26 | Jiangsu Hengrui Medicine Co., Ltd. | nova toxina e método de preparação de intermediário da mesma |
| EP3454857A1 (en) | 2016-05-10 | 2019-03-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of autoimmune inflammatory diseases |
| EP3619199B1 (en) | 2017-05-03 | 2021-07-07 | Idorsia Pharmaceuticals Ltd | Preparation of 2-([1,2,3]triazol-2-yl)-benzoic acid derivatives |
| WO2019057946A1 (en) | 2017-09-25 | 2019-03-28 | F. Hoffmann-La Roche Ag | MULTI-CYCLIC AROMATIC COMPOUNDS AS D-FACTOR INHIBITORS |
| WO2020007964A1 (en) | 2018-07-05 | 2020-01-09 | Idorsia Pharmaceuticals Ltd | 2-(2-azabicyclo[3.1.0]hexan-1-yl)-1h-benzimidazole derivatives |
| WO2020007977A1 (en) | 2018-07-06 | 2020-01-09 | Idorsia Pharmaceuticals Ltd | 7-trifluoromethyl-[1,4]diazepan derivatives |
| WO2020099511A1 (en) | 2018-11-14 | 2020-05-22 | Idorsia Pharmaceuticals Ltd | Benzimidazole-2-methyl-morpholine derivatives |
| EP4196118A1 (en) | 2020-08-13 | 2023-06-21 | Boehringer Ingelheim International GmbH | Treatment of cognitive impairement associated with schizophrenia |
| CA3195702A1 (en) | 2020-10-13 | 2022-04-21 | Boehringer Ingelheim International Gmbh | Process of reworking |
| JP7681113B2 (ja) * | 2021-02-02 | 2025-05-21 | メッドシャイン ディスカバリー インコーポレイテッド | テトラヒドロピロロ環化合物及びその使用 |
| TW202400149A (zh) | 2022-05-13 | 2024-01-01 | 瑞士商愛杜西亞製藥有限公司 | 經噻唑并芳基-甲基取代之環狀肼-n-甲醯胺衍生物 |
| WO2025224168A1 (en) | 2024-04-24 | 2025-10-30 | Idorsia Pharmaceuticals Ltd | Aryl sulfone and sulfanone derivatives as orexin receptor modulators |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH621126A5 (enExample) | 1974-02-07 | 1981-01-15 | Plantex Ltd | |
| WO1995029922A1 (en) | 1994-04-29 | 1995-11-09 | Pharmacia & Upjohn Company | Methanol derivatives for treatment of retroviral infections especially hiv infections |
| PT1289955E (pt) * | 2000-06-16 | 2005-08-31 | Smithkline Beecham Plc | Piperidinas para utilizacao como antagonistas dos receptores da orexina |
| JP2004533989A (ja) | 2000-11-20 | 2004-11-11 | サイオス インコーポレイテッド | p38キナーゼのピペリジン/ピペラジン型阻害剤 |
| WO2002044172A1 (en) | 2000-11-28 | 2002-06-06 | Smithkline Beecham P.L.C. | Morpholine derivatives as antagonists of orexin receptors |
| JP4309135B2 (ja) * | 2001-05-05 | 2009-08-05 | スミスクライン ビーチャム ピー エル シー | N−アロイルサイクリックアミン |
| JP2004534026A (ja) * | 2001-05-05 | 2004-11-11 | スミスクライン ビーチャム パブリック リミテッド カンパニー | オレキシン受容体アンタゴニストとしてのn−アロイルサイクリックアミン誘導体 |
| GB0111341D0 (en) | 2001-05-10 | 2001-07-04 | Bp Chem Int Ltd | Novel polymerisation catalysts |
| GB0115862D0 (en) * | 2001-06-28 | 2001-08-22 | Smithkline Beecham Plc | Compounds |
| PL367677A1 (en) * | 2001-06-28 | 2005-03-07 | Smithkline Beecham P.L.C. | N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| GB0124463D0 (en) * | 2001-10-11 | 2001-12-05 | Smithkline Beecham Plc | Compounds |
| GB0127145D0 (en) | 2001-11-10 | 2002-01-02 | Smithkline Beecham | Compounds |
| US6727247B2 (en) * | 2001-12-10 | 2004-04-27 | Hoffman-La Roche Inc. | Substituted benzothiazole amide derivatives |
| GB0130335D0 (en) * | 2001-12-19 | 2002-02-06 | Smithkline Beecham Plc | Compounds |
| GB0130393D0 (en) * | 2001-12-19 | 2002-02-06 | Smithkline Beecham Plc | Compounds |
| US6995144B2 (en) | 2002-03-14 | 2006-02-07 | Eisai Co., Ltd. | Nitrogen containing heterocyclic compounds and medicines containing the same |
| WO2004026866A1 (en) * | 2002-09-18 | 2004-04-01 | Glaxo Group Limited | N-aroyl cyclic amines as orexin receptor antagonists |
| GB0225938D0 (en) | 2002-11-06 | 2002-12-11 | Glaxo Group Ltd | Novel compounds |
| GB0225944D0 (en) * | 2002-11-06 | 2002-12-11 | Glaxo Group Ltd | Novel compounds |
| GB0225884D0 (en) * | 2002-11-06 | 2002-12-11 | Glaxo Group Ltd | Novel compounds |
| ATE435210T1 (de) * | 2003-03-26 | 2009-07-15 | Actelion Pharmaceuticals Ltd | Tetrahydroisochinolylacetamidderivate zur verwendung als orexinrezeptorantagonisten |
| CA2520839A1 (en) * | 2003-04-28 | 2004-11-11 | Actelion Pharmaceuticals Ltd | Quinoxalinone-3- one derivatives as orexin receptor antagonists |
| HRP20150371T1 (hr) * | 2004-03-01 | 2015-05-08 | Actelion Pharmaceuticals Ltd. | Supstituirani derivati 1,2,3,4-tetrahidroizokinolina |
| US20060014733A1 (en) | 2004-07-19 | 2006-01-19 | Pfizer Inc | Histamine-3 agonists and antagonists |
| PL2069332T3 (pl) | 2006-08-15 | 2011-07-29 | Actelion Pharmaceuticals Ltd | Związki azetydynowe jako antagoniści receptorów oreksynowych |
| EP2079690B1 (en) * | 2006-09-29 | 2010-09-15 | Actelion Pharmaceuticals Ltd. | 3-aza-bicyclo[3.1.0]hexane derivatives |
| WO2008065626A2 (en) | 2006-12-01 | 2008-06-05 | Actelion Pharmaceuticals Ltd | 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperidine derivativesas orexin receptor inhibitors |
| CL2008000836A1 (es) | 2007-03-26 | 2008-11-07 | Actelion Pharmaceuticals Ltd | Compuestos derivados de tiazolidina, antagonistas del receptor de orexina; composicion farmaceutica que los comprende; y su uso en el tratamiento de neurosis emocional, depresion grave, trastornos psicoticos, alzheimer, parkinson, dolor, entre otras. |
| US20100222328A1 (en) | 2007-05-14 | 2010-09-02 | Hamed Aissaoui | 2-cyclopropyl-thiazole derivatives |
| HRP20120240T1 (hr) | 2007-05-23 | 2012-04-30 | Merck Sharp & Dohme Corp. | Piridil piperidin antagonisti receptora za oreksin |
| US8030495B2 (en) | 2007-05-23 | 2011-10-04 | Coleman Paul J | Cyclopropyl pyrrolidine orexin receptor antagonists |
| CA2691373A1 (en) | 2007-07-03 | 2009-01-08 | Actelion Pharmaceuticals Ltd | 3-aza-bicyclo[3.3.0]octane compounds |
| AR067665A1 (es) | 2007-07-27 | 2009-10-21 | Actelion Pharmaceuticals Ltd | Derivados de trans-3- aza-biciclo ( 3.1.0) hexano |
| NZ583487A (en) | 2007-07-27 | 2011-09-30 | Actelion Pharmaceuticals Ltd | 2-aza-bicyclo[3.3.0]octane derivatives |
| EP2207778A2 (en) | 2007-09-24 | 2010-07-21 | Actelion Pharmaceuticals Ltd. | Pyrrolidines and piperidines as orexin receptor antagonists |
| NZ588080A (en) | 2008-02-21 | 2012-04-27 | Actelion Pharmaceuticals Ltd | 2-Aza-bicyclo[2.2.1]heptane derivatives |
| CA2722347A1 (en) | 2008-04-30 | 2009-11-05 | Actelion Pharmaceuticals Ltd | Piperidine and pyrrolidine compounds |
| TW200940822A (en) * | 2009-05-07 | 2009-10-01 | Wan Chi Steel Ind Co Ltd | Water wheel mechanism with sun-and-planet type blade |
-
2007
- 2007-12-27 CL CL200703827A patent/CL2007003827A1/es unknown
- 2007-12-27 AR ARP070105930A patent/AR064561A1/es not_active Application Discontinuation
- 2007-12-27 TW TW096150631A patent/TW200833328A/zh unknown
- 2007-12-28 BR BRPI0720876-6A patent/BRPI0720876A2/pt not_active IP Right Cessation
- 2007-12-28 RU RU2009128739/04A patent/RU2460732C2/ru not_active IP Right Cessation
- 2007-12-28 JP JP2009543566A patent/JP2010514751A/ja active Pending
- 2007-12-28 ES ES07859531T patent/ES2364297T3/es active Active
- 2007-12-28 DE DE602007013937T patent/DE602007013937D1/de active Active
- 2007-12-28 HR HR20110509T patent/HRP20110509T1/hr unknown
- 2007-12-28 DK DK07859531.1T patent/DK2094690T3/da active
- 2007-12-28 MX MX2009006860A patent/MX2009006860A/es active IP Right Grant
- 2007-12-28 AU AU2007340944A patent/AU2007340944B2/en not_active Expired - Fee Related
- 2007-12-28 AT AT07859531T patent/ATE505467T1/de active
- 2007-12-28 CN CN2007800483236A patent/CN101568536B/zh not_active Expired - Fee Related
- 2007-12-28 EP EP07859531A patent/EP2094690B1/en active Active
- 2007-12-28 NZ NZ578642A patent/NZ578642A/en not_active IP Right Cessation
- 2007-12-28 CA CA002669821A patent/CA2669821A1/en not_active Abandoned
- 2007-12-28 PT PT07859531T patent/PT2094690E/pt unknown
- 2007-12-28 PL PL07859531T patent/PL2094690T3/pl unknown
- 2007-12-28 WO PCT/IB2007/055326 patent/WO2008081399A2/en not_active Ceased
- 2007-12-28 US US12/521,453 patent/US8288435B2/en not_active Expired - Fee Related
- 2007-12-28 SI SI200730639T patent/SI2094690T1/sl unknown
- 2007-12-28 MY MYPI20092751A patent/MY157344A/en unknown
- 2007-12-28 KR KR1020097015732A patent/KR20090094168A/ko not_active Ceased
-
2009
- 2009-06-17 MA MA32004A patent/MA31000B1/fr unknown
- 2009-07-27 NO NO20092762A patent/NO20092762L/no not_active Application Discontinuation
- 2009-07-27 ZA ZA200905229A patent/ZA200905229B/xx unknown
-
2011
- 2011-07-13 CY CY20111100681T patent/CY1111705T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010514751A5 (enExample) | ||
| CN101568536B (zh) | 作为食欲素受体拮抗剂的2-氮杂-双环[3.1.0]己烷衍生物 | |
| US8236801B2 (en) | 2-aza-bicyclo[2.2.1]heptane derivatives | |
| EP2185512B1 (en) | Trans-3-aza-bicyclo[3.1.0]hexane derivatives | |
| US8063099B2 (en) | Trans-3-aza-bicyclo[3.1.0]hexane derivatives | |
| EP2079690B1 (en) | 3-aza-bicyclo[3.1.0]hexane derivatives | |
| RU2009139285A (ru) | Производные тиазолидина в качестве антагонистов рецептора орексина | |
| US20110212968A1 (en) | Phenethylamide derivatives and their heterocyclic analogues | |
| CA2693820A1 (en) | 2-aza-bicyclo[3.3.0]octane derivatives | |
| CA2685743A1 (en) | 2-cyclopropyl-thiazole derivatives | |
| HK1136554B (en) | 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists |